High-level	O
replication	O
of	O
human	O
immunodeficiency	O
virus	O
in	O
thymocytes	B-cell_type
requires	O
NF-kappaB	B-protein
activation	O
through	O
interaction	O
with	O
thymic	B-cell_type
epithelial	I-cell_type
cells	I-cell_type
.	O

We	O
have	O
previously	O
demonstrated	O
that	O
interaction	O
of	O
infected	O
thymocytes	B-cell_type
with	O
autologous	O
thymic	B-cell_type
epithelial	I-cell_type
cells	I-cell_type
(	O
TEC	B-cell_type
)	O
is	O
a	O
prerequisite	O
for	O
a	O
high	O
level	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
replication	O
in	O
thymocytes	B-cell_type
(	O
M.Rothe	O
,	O
L.Chene	O
,	O
M.Nugeyre	O
,	O
F.Barre-Sinoussi	O
,	O
and	O
N.Israel	O
,	O
J.Virol.72	O
:	O
5852-5861	O
,	O
1998	O
)	O
.	O

We	O
report	O
here	O
that	O
this	O
activation	O
of	O
HIV	O
replication	O
takes	O
place	O
at	O
the	O
transcriptional	O
level	O
through	O
activation	O
of	O
the	O
Rel/NF-kappaB	B-protein
transcription	B-protein
factors	I-protein
.	O

We	O
first	O
demonstrate	O
that	O
an	O
HIV-1	O
provirus	O
(	O
SF-2	O
strain	O
)	O
very	O
effectively	O
replicates	O
in	O
thymocytes	B-cell_type
cocultured	O
with	O
TEC	B-cell_type
whereas	O
this	O
provirus	O
,	O
with	O
kappaB	B-DNA
sites	I-DNA
deleted	O
,	O
fails	O
to	O
replicate	O
.	O

We	O
provide	O
evidence	O
that	O
several	O
NF-kappaB	B-protein
complexes	I-protein
are	O
constitutively	O
found	O
in	O
the	O
nuclei	O
of	O
thymocytes	B-cell_type
either	O
freshly	O
isolated	O
from	O
the	O
thymus	O
or	O
maintained	O
in	O
coculture	O
with	O
autologous	O
or	O
heterologous	O
TEC	B-cell_type
.	O

The	O
prevalent	O
complex	O
is	O
the	O
heterodimer	B-protein
p50-p65	I-protein
.	O

NF-kappaB	B-protein
activity	O
is	O
tightly	O
correlated	O
with	O
the	O
transcriptional	O
activity	O
of	O
a	O
long	B-DNA
terminal	I-DNA
repeat	I-DNA
(	O
LTR	B-DNA
)	O
of	O
HIV-1	O
transfected	O
in	O
thymocytes	B-cell_type
.	O

The	O
cotransfection	O
of	O
this	O
LTR	B-DNA
with	O
a	O
mutated	O
IkappaBalpha	B-protein
molecule	I-protein
formally	O
demonstrates	O
that	O
LTR	B-DNA
transactivation	O
is	O
regulated	O
by	O
members	O
of	O
the	O
Rel/NF-kappaB	B-protein
family	I-protein
in	O
thymocytes	B-cell_type
.	O

We	O
also	O
showed	O
that	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
(	O
TNF	B-protein
)	O
and	O
to	O
a	O
lesser	O
extent	O
interleukin-1	B-protein
(	O
IL-1	B-protein
)	O
,	O
secreted	O
within	O
the	O
coculture	O
,	O
induce	O
NF-kappaB	B-protein
activity	O
and	O
a	O
correlative	O
LTR	B-DNA
transactivation	O
.	O

However	O
IL-7	B-protein
,	O
a	O
crucial	O
factor	O
for	O
thymopoiesis	O
that	O
is	O
secreted	O
mainly	O
by	O
TEC	B-cell_type
,	O
is	O
a	O
necessary	O
cofactor	O
for	O
NF-kappaB	B-protein
activation	O
elicited	O
by	O
TNF	B-protein
or	O
IL-1	B-protein
.	O

Together	O
,	O
these	O
data	O
indicate	O
that	O
NF-kappaB	B-protein
activation	O
,	O
required	O
for	O
a	O
high	O
level	O
of	O
HIV	O
replication	O
in	O
thymocytes	B-cell_type
,	O
is	O
regulated	O
in	O
a	O
specific	O
manner	O
in	O
the	O
thymic	O
microenvironment	O
which	O
provides	O
the	O
necessary	O
cytokines	O
:	O
TNF	B-protein
,	O
IL-1	B-protein
,	O
and	O
IL-7	B-protein
.	O

JouRrNAL	NULL
or	NULL
VirRoLOoGY	NULL
,	NULL
Mar	NULL
.	NULL

1999	NULL
,	NULL
p.	NULL
2064-2073	NULL
0022-538	NULL
X/99/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

73	NULL
,	NULL
No	NULL
.	NULL

3	NULL
Copyright	NULL
©	NULL
1999	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

High-Level	NULL
Replication	NULL
of	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
in	NULL
Thymocytes	NULL
Requires	NULL
NF-	NULL
«	NULL
B	NULL
Activation	NULL
through	NULL
Interaction	NULL
with	NULL
Thymic	NULL
Epithelial	NULL
Cells	NULL
LAURENT	NULL
CHENE	NULL
,	NULL
MARIE-THERESE	NULL
NUGEYRE	NULL
,	NULL
FRANCOISE	NULL
BARRE-SINOUSSL	NULL
,	NULL
AND	NULL
NICOLE	NULL
ISRAEL*	NULL
Unité	NULL
de	NULL
Biologie	NULL
des	NULL
Rétrovirus	NULL
,	NULL
Institut	NULL
Pasteur	NULL
,	NULL
75724	NULL
Paris	NULL
Cedex	NULL
15	NULL
,	NULL
France	NULL
Received	NULL
6	NULL
August	NULL
1998/Accepted	NULL
23	NULL
November	NULL
1998	NULL
We	NULL
have	NULL
previously	NULL
demonstrated	NULL
that	NULL
interaction	NULL
of	NULL
infected	NULL
thymocytes	NULL
with	NULL
autologous	NULL
thymic	NULL
epithelial	NULL
cells	NULL
(	NULL
TEC	NULL
)	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
a	NULL
high	NULL
level	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
replication	NULL
in	NULL
thymocytes	NULL
(	NULL
M.	NULL
Rothe	NULL
,	NULL
L.	NULL
Chéne	NULL
,	NULL
M.	NULL
Nugeyre	NULL
,	NULL
F.	NULL
Barré-Sinoussi	NULL
,	NULL
and	NULL
N.	NULL
Israél	NULL
,	NULL
J.	NULL
Virol	NULL
.	NULL

72:5852-5861	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
this	NULL
activation	NULL
of	NULL
HIV	NULL
replication	NULL
takes	NULL
place	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
through	NULL
activation	NULL
of	NULL
the	NULL
Rel/NF-B	NULL
transcription	NULL
factors	NULL
.	NULL

We	NULL
first	NULL
demonstrate	NULL
that	NULL
an	NULL
HIV-1	NULL
provirus	NULL
(	NULL
SF-2	NULL
strain	NULL
)	NULL
very	NULL
effectively	NULL
replicates	NULL
in	NULL
thymocytes	NULL
cocultured	NULL
with	NULL
TEC	NULL
whereas	NULL
this	NULL
provirus	NULL
,	NULL
with	NULL
xB	NULL
sites	NULL
deleted	NULL
,	NULL
fails	NULL
to	NULL
replicate	NULL
.	NULL

We	NULL
provide	NULL
evidence	NULL
that	NULL
several	NULL
NF-KB	NULL
complexes	NULL
are	NULL
constitutively	NULL
found	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
thymocytes	NULL
either	NULL
freshly	NULL
isolated	NULL
from	NULL
the	NULL
thymus	NULL
or	NULL
maintained	NULL
in	NULL
coculture	NULL
with	NULL
autologous	NULL
or	NULL
heterologous	NULL
TEC	NULL
.	NULL

The	NULL
prevalent	NULL
complex	NULL
is	NULL
the	NULL
heterodimer	NULL
p50-p65	NULL
.	NULL

NF-B	NULL
activity	NULL
is	NULL
tightly	NULL
correlated	NULL
with	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
a	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
of	NULL
HIV-1	NULL
transfected	NULL
in	NULL
thymocytes	NULL
.	NULL

The	NULL
cotransfection	NULL
of	NULL
this	NULL
LTR	NULL
with	NULL
a	NULL
mutated	NULL
IxBa	NULL
molecule	NULL
formally	NULL
demonstrates	NULL
that	NULL
LTR	NULL
transactivation	NULL
is	NULL
regulated	NULL
by	NULL
members	NULL
of	NULL
the	NULL
Rel/NF-B	NULL
family	NULL
in	NULL
thymocytes	NULL
.	NULL

We	NULL
also	NULL
showed	NULL
that	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
,	NULL
secreted	NULL
within	NULL
the	NULL
coculture	NULL
,	NULL
induce	NULL
NF-KB	NULL
activity	NULL
and	NULL
a	NULL
correlative	NULL
LTR	NULL
transactivation	NULL
.	NULL

However	NULL
IL-7	NULL
,	NULL
a	NULL
crucial	NULL
factor	NULL
for	NULL
thymopoiesis	NULL
that	NULL
is	NULL
secreted	NULL
mainly	NULL
by	NULL
TEC	NULL
,	NULL
is	NULL
a	NULL
necessary	NULL
cofactor	NULL
for	NULL
NF-KB	NULL
activation	NULL
elicited	NULL
by	NULL
TNF	NULL
or	NULL
IL-1	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
NF-KB	NULL
activation	NULL
,	NULL
required	NULL
for	NULL
a	NULL
high	NULL
level	NULL
of	NULL
HIV	NULL
replication	NULL
in	NULL
thymocytes	NULL
,	NULL
is	NULL
regulated	NULL
in	NULL
a	NULL
specific	NULL
manner	NULL
in	NULL
the	NULL
thymic	NULL
microenvironment	NULL
which	NULL
provides	NULL
the	NULL
necessary	NULL
cytokines	NULL
:	NULL
TNF	NULL
,	NULL
IL-1	NULL
,	NULL
and	NULL
IL-7	NULL
.	NULL

One	NULL
explanation	NULL
(	NULL
24	NULL
,	NULL
61	NULL
)	NULL
for	NULL
the	NULL
depletion	NULL
in	NULL
the	NULL
number	NULL
of	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
,	NULL
which	NULL
is	NULL
the	NULL
hallmark	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
infection	NULL
,	NULL
is	NULL
the	NULL
exhaustion	NULL
of	NULL
the	NULL
T-cell	NULL
turnover	NULL
,	NULL
which	NULL
has	NULL
to	NULL
occur	NULL
at	NULL
a	NULL
very	NULL
high	NULL
rate	NULL
to	NULL
replace	NULL
the	NULL
cells	NULL
permanently	NULL
destroyed	NULL
by	NULL
the	NULL
virus	NULL
(	NULL
9	NULL
)	NULL
.	NULL

This	NULL
high-turnover	NULL
model	NULL
does	NULL
not	NULL
take	NULL
into	NULL
account	NULL
the	NULL
possible	NULL
impairment	NULL
of	NULL
T-cell	NULL
renewal	NULL
caused	NULL
by	NULL
HIV	NULL
infection	NULL
of	NULL
primary	NULL
lymphoid	NULL
organs	NULL
(	NULL
20	NULL
,	NULL
40	NULL
)	NULL
.	NULL

A	NULL
number	NULL
of	NULL
studies	NULL
suggested	NULL
a	NULL
correlation	NULL
between	NULL
the	NULL
rapid	NULL
progression	NULL
toward	NULL
AIDS	NULL
of	NULL
some	NULL
pediatric	NULL
seropositive	NULL
patients	NULL
and	NULL
thymic	NULL
alterations	NULL
including	NULL
a	NULL
profound	NULL
disorganization	NULL
of	NULL
the	NULL
epithelial	NULL
network	NULL
(	NULL
28	NULL
,	NULL
45	NULL
,	NULL
47	NULL
)	NULL
and	NULL
thymocyte	NULL
depletion	NULL
.	NULL

Furthermore	NULL
,	NULL
antiretro-viral	NULL
treatment	NULL
applied	NULL
to	NULL
HIV-infected	NULL
SCID-hu	NULL
mice	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
a	NULL
complete	NULL
renewal	NULL
of	NULL
the	NULL
mature	NULL
thymocyte	NULL
population	NULL
,	NULL
underlining	NULL
the	NULL
possibility	NULL
of	NULL
an	NULL
impairment	NULL
either	NULL
of	NULL
progenitor	NULL
thymocyte	NULL
function	NULL
or	NULL
of	NULL
stromal	NULL
cell	NULL
function	NULL
(	NULL
65	NULL
)	NULL
.	NULL

To	NULL
better	NULL
understand	NULL
the	NULL
pathogenesis	NULL
of	NULL
HIV	NULL
infection	NULL
in	NULL
the	NULL
thymus	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
identify	NULL
the	NULL
stimuli	NULL
and	NULL
mechanisms	NULL
controlling	NULL
the	NULL
virus	NULL
replication	NULL
and	NULL
spreading	NULL
within	NULL
this	NULL
or-gan	NULL
.	NULL

Most	NULL
thymocytes	NULL
are	NULL
susceptible	NULL
to	NULL
HIV	NULL
infection	NULL
in	NULL
vitro	NULL
(	NULL
58-60	NULL
)	NULL
and	NULL
in	NULL
the	NULL
SCID-hu	NULL
mouse	NULL
model	NULL
(	NULL
2	NULL
,	NULL
32	NULL
,	NULL
54	NULL
,	NULL
56	NULL
)	NULL
.	NULL

We	NULL
previously	NULL
determined	NULL
the	NULL
factors	NULL
physiologically	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
HIV	NULL
replication	NULL
in	NULL
thymocytes	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
interaction	NULL
of	NULL
infected	NULL
thymocytes	NULL
with	NULL
thymic	NULL
epithelial	NULL
cells	NULL
(	NULL
TEC	NULL
)	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
a	NULL
high	NULL
level	NULL
of	NULL
HIV	NULL
replication	NULL
in	NULL
thymocytes	NULL
.	NULL

We	NULL
determined	NULL
that	NULL
this	NULL
cell-to-cell	NULL
contact	NULL
,	NULL
while	NULL
necessary	NULL
,	NULL
is	NULL
not	NULL
per	NULL
se	NULL
the	NULL
effector	NULL
of	NULL
HIV	NULL
replication	NULL
but	NULL
,	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Unité	NULL
de	NULL
Biologie	NULL
des	NULL
Rétrovirus	NULL
,	NULL
Institut	NULL
Pasteur	NULL
,	NULL
28	NULL
rue	NULL
du	NULL
Dr	NULL
Roux	NULL
,	NULL
75724	NULL
Paris	NULL
Cedex	NULL
15	NULL
,	NULL
France	NULL
.	NULL

Phone	NULL
:	NULL
33	NULL
1	NULL
45	NULL
68	NULL
89	NULL
44/87	NULL
33	NULL
.	NULL

Fax	NULL
:	NULL
33	NULL
1	NULL
45	NULL
68	NULL
89	NULL
57	NULL
.	NULL

E-mail	NULL
:	NULL
nisrael	NULL
@	NULL
pasteur.fr	NULL
.	NULL

2064	NULL
rather	NULL
,	NULL
that	NULL
soluble	NULL
factors	NULL
present	NULL
in	NULL
the	NULL
coculture	NULL
synergize	NULL
to	NULL
induce	NULL
HIV	NULL
replication	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Two	NULL
types	NULL
of	NULL
factors	NULL
were	NULL
identified	NULL
according	NULL
to	NULL
their	NULL
role	NULL
,	NULL
either	NULL
in	NULL
cell	NULL
activation	NULL
(	NULL
such	NULL
as	NULL
tumor	NULL
necrosis	NULL
factor	NULL
[	NULL
TNF	NULL
]	NULL
,	NULL
interleukin-1	NULL
[	NULL
IL-1	NULL
]	NULL
,	NULL
and	NULL
IL-6	NULL
)	NULL
(	NULL
67	NULL
)	NULL
or	NULL
in	NULL
cell	NULL
proliferation	NULL
or	NULL
protection	NULL
against	NULL
apoptosis	NULL
(	NULL
such	NULL
as	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
[	NULL
GM-CSF	NULL
]	NULL
)	NULL
(	NULL
3	NULL
,	NULL
27	NULL
,	NULL
31	NULL
)	NULL
.	NULL

The	NULL
requirement	NULL
for	NULL
TNF	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
for	NULL
IL-1	NULL
in	NULL
HIV	NULL
replication	NULL
during	NULL
the	NULL
coculture	NULL
of	NULL
thymocytes	NULL
and	NULL
TEC	NULL
suggests	NULL
that	NULL
a	NULL
major	NULL
role	NULL
of	NULL
this	NULL
interaction	NULL
might	NULL
be	NULL
the	NULL
induction	NULL
of	NULL
NF-kB	NULL
activation	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
would	NULL
activate	NULL
transcription	NULL
from	NULL
the	NULL
two	NULL
xB	NULL
sites	NULL
present	NULL
in	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
composed	NULL
of	NULL
homodimers	NULL
and	NULL
heterodimers	NULL
of	NULL
members	NULL
of	NULL
the	NULL
Rel/NF-kB	NULL
family	NULL
.	NULL

To	NULL
date	NULL
,	NULL
five	NULL
proteins	NULL
belonging	NULL
to	NULL
the	NULL
NF-kB	NULL
family	NULL
have	NULL
been	NULL
identified	NULL
:	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
RelB	NULL
,	NULL
p50/p105	NULL
,	NULL
and	NULL
p52/p100	NULL
(	NULL
5	NULL
,	NULL
33	NULL
,	NULL
39	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
dimers	NULL
are	NULL
sequestered	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
unstimulated	NULL
cells	NULL
via	NULL
interactions	NULL
with	NULL
a	NULL
family	NULL
of	NULL
inhibitory	NULL
proteins	NULL
called	NULL
IxBs	NULL
(	NULL
IxBa	NULL
,	NULL
IxBB	NULL
,	NULL
and	NULL
IxBg	NULL
)	NULL
(	NULL
64	NULL
)	NULL
.	NULL

Following	NULL
activation	NULL
by	NULL
various	NULL
immune	NULL
system	NULL
and	NULL
inflammatory	NULL
stimuli	NULL
,	NULL
IxB	NULL
molecules	NULL
are	NULL
degraded	NULL
through	NULL
the	NULL
ubiquitin-proteasome	NULL
path-way	NULL
,	NULL
thus	NULL
allowing	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
and	NULL
activation	NULL
of	NULL
its	NULL
target	NULL
genes	NULL
(	NULL
39	NULL
)	NULL
.	NULL

To	NULL
verify	NULL
the	NULL
hypothesis	NULL
that	NULL
thymic	NULL
microenvironment	NULL
controls	NULL
HIV	NULL
replication	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
,	NULL
we	NULL
used	NULL
autologous	NULL
mixed	NULL
culture	NULL
of	NULL
TEC	NULL
and	NULL
thymocytes	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
48	NULL
)	NULL
.	NULL

We	NULL
first	NULL
demonstrated	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
a	NULL
high	NULL
level	NULL
of	NULL
HIV	NULL
replication	NULL
in	NULL
thymocytes	NULL
,	NULL
since	NULL
a	NULL
provirus	NULL
with	NULL
its	NULL
two	NULL
kB	NULL
sites	NULL
deleted	NULL
failed	NULL
to	NULL
replicate	NULL
even	NULL
in	NULL
coculture	NULL
with	NULL
TEC	NULL
.	NULL

We	NULL
then	NULL
dissected	NULL
the	NULL
mechanism	NULL
underlying	NULL
this	NULL
activation	NULL
process	NULL
.	NULL

We	NULL
first	NULL
demonstrated	NULL
that	NULL
coculture	NULL
with	NULL
TEC	NULL
led	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
voL	NULL
.	NULL

73	NULL
,	NULL
1999	NULL
nuclear	NULL
NF-kB	NULL
complexes	NULL
in	NULL
thymocytes	NULL
.	NULL

The	NULL
relevance	NULL
of	NULL
these	NULL
NF-kB	NULL
complexes	NULL
was	NULL
demonstrated	NULL
by	NULL
specific	NULL
inhibition	NULL
of	NULL
LTR	NULL
transactivation	NULL
by	NULL
a	NULL
mutated	NULL
form	NULL
of	NULL
the	NULL
IxBa	NULL
constitutively	NULL
inhibiting	NULL
NF-kB	NULL
.	NULL

We	NULL
also	NULL
showed	NULL
that	NULL
TNF	NULL
could	NULL
not	NULL
replace	NULL
the	NULL
activating	NULL
effect	NULL
of	NULL
the	NULL
coculture	NULL
and	NULL
that	NULL
IL-7	NULL
,	NULL
a	NULL
TEC-secreted	NULL
factor	NULL
crucial	NULL
for	NULL
thymopoiesis	NULL
(	NULL
21	NULL
,	NULL
22	NULL
,	NULL
46	NULL
)	NULL
,	NULL
was	NULL
required	NULL
to	NULL
obtain	NULL
a	NULL
strong	NULL
and	NULL
prolonged	NULL
TNF-induced	NULL
NF-xB	NULL
activity	NULL
.	NULL

We	NULL
provide	NULL
correlative	NULL
evidence	NULL
that	NULL
the	NULL
association	NULL
of	NULL
these	NULL
two	NULL
cytokines	NULL
is	NULL
sufficient	NULL
to	NULL
induce	NULL
the	NULL
transactivation	NULL
of	NULL
the	NULL
NF-B-dependent	NULL
HIV	NULL
LTR	NULL
.	NULL

Taking	NULL
the	NULL
results	NULL
together	NULL
,	NULL
we	NULL
show	NULL
here	NULL
that	NULL
cytokines	NULL
provided	NULL
by	NULL
different	NULL
cell	NULL
types	NULL
within	NULL
the	NULL
thymus	NULL
combine	NULL
their	NULL
effects	NULL
to	NULL
sustain	NULL
a	NULL
high	NULL
level	NULL
of	NULL
HIV	NULL
transcription	NULL
in	NULL
thymocytes	NULL
through	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
.	NULL

(	NULL
i	NULL
)	NULL
Antibodies	NULL
.	NULL

To	NULL
characterize	NULL
both	NULL
TEC	NULL
and	NULL
thymocytes	NULL
popula-tions	NULL
,	NULL
the	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
MAbs	NULL
)	NULL
used	NULL
were	NULL
against	NULL
CD3	NULL
(	NULL
X35	NULL
)	NULL
,	NULL
CD7	NULL
(	NULL
8H8,1	NULL
)	NULL
,	NULL
CD14	NULL
(	NULL
RMOS2	NULL
)	NULL
,	NULL
CD83	NULL
(	NULL
HB15A	NULL
)	NULL
,	NULL
cytokeratin	NULL
(	NULL
KL1	NULL
)	NULL
,	NULL
and	NULL
vimentin	NULL
(	NULL
vim3B4	NULL
)	NULL
.	NULL

Immunoglobulin	NULL
G1	NULL
(	NULL
IgG1	NULL
)	NULL
(	NULL
MARK1	NULL
)	NULL
and	NULL
IgG2a	NULL
(	NULL
U7.27	NULL
)	NULL
were	NULL
used	NULL
as	NULL
negative	NULL
controls	NULL
.	NULL

All	NULL
these	NULL
antibodies	NULL
were	NULL
purchased	NULL
from	NULL
Immunotech	NULL
(	NULL
Marseilles	NULL
,	NULL
France	NULL
)	NULL
,	NULL
except	NULL
vim3B4	NULL
,	NULL
which	NULL
was	NULL
purchased	NULL
from	NULL
Bochringer	NULL
Mannheim	NULL
(	NULL
Meylan	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Conjugated	NULL
MAbs	NULL
,	NULL
including	NULL
CD4-phycoerythrin	NULL
(	NULL
PE	NULL
)	NULL
(	NULL
13B8.2	NULL
)	NULL
,	NULL
CD8-fluorescein	NULL
isothicyanate	NULL
(	NULL
FITC	NULL
)	NULL
(	NULL
B9.11	NULL
)	NULL
,	NULL
control	NULL
IgG1-PE	NULL
(	NULL
679.1Mc7	NULL
)	NULL
and	NULL
IgG1-FITC	NULL
(	NULL
679.1Mc7	NULL
)	NULL
,	NULL
goat-anti-rabbit-FITC	NULL
,	NULL
and	NULL
goat-anti-mouse-FITC	NULL
,	NULL
were	NULL
purchased	NULL
from	NULL
Immunotech	NULL
.	NULL

Rabbit	NULL
polyclonal	NULL
serum	NULL
against	NULL
TNF	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
J.-M.	NULL
Cavaillon	NULL
,	NULL
Pasteur	NULL
Institute	NULL
(	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
.	NULL

IL-1	NULL
receptor	NULL
antagonist	NULL
(	NULL
IL-1ra	NULL
)	NULL
and	NULL
mouse	NULL
MAb	NULL
against	NULL
IL-7	NULL
were	NULL
purchased	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
(	NULL
Minneapolis	NULL
,	NULL
Minn.	NULL
)	NULL
.	NULL

MAb	NULL
against	NULL
IL-1B	NULL
(	NULL
B-A15	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Diaclone	NULL
Research	NULL
(	NULL
Besangon	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Mouse	NULL
MAb	NULL
against	NULL
IL-6	NULL
(	NULL
AH65	NULL
)	NULL
and	NULL
mouse	NULL
MAb	NULL
against	NULL
the	NULL
a	NULL
chain	NULL
of	NULL
the	NULL
IL-7	NULL
receptor	NULL
(	NULL
IL-7Ra	NULL
)	NULL
CDw127	NULL
(	NULL
R34.34	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Immunotech	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
Cytokines	NULL
.	NULL

Human	NULL
recombinant	NULL
cytokines	NULL
GM-CSF	NULL
,	NULL
IL-1	NULL
$	NULL
,	NULL
and	NULL
TNFa	NULL
were	NULL
purchased	NULL
from	NULL
Genzyme	NULL
Corp.	NULL
(	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

.	NULL

IL-6	NULL
and	NULL
IL-7	NULL
were	NULL
purchased	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
.	NULL

Plasmids	NULL
.	NULL

All	NULL
reporter	NULL
constructs	NULL
and	NULL
plasmids	NULL
used	NULL
in	NULL
this	NULL
work	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
LTR-luc	NULL
construct	NULL
carries	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
U3R	NULL
(	NULL
Be/	NULL
[	NULL
I-HindIII	NULL
fragment	NULL
)	NULL
of	NULL
the	NULL
HIV-1y	NULL
L	NULL
4	NULL
;	NULL
LTR	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
3Enh-TK-lue	NULL
construct	NULL
contains	NULL
three	NULL
copies	NULL
of	NULL
a	NULL
synthetic	NULL
oligonucleotide	NULL
encompassing	NULL
the	NULL
two	NULL
10-bp	NULL
repeats	NULL
of	NULL
the	NULL
HIV-1y	NULL
ar	NULL
enhancer	NULL
(	NULL
-107	NULL
to	NULL
-76	NULL
)	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
truncated	NULL
thymidine	NULL
kinase	NULL
(	NULL
TK	NULL
)	NULL
promoter	NULL
(	NULL
-105	NULL
to	NULL
+51	NULL
)	NULL
of	NULL
herpes	NULL
simplex	NULL
virus	NULL
in	NULL
a	NULL
TK-luc	NULL
expression	NULL
vector	NULL
(	NULL
19	NULL
)	NULL
.	NULL

LTRAxB	NULL
was	NULL
obtained	NULL
by	NULL
insertion	NULL
into	NULL
the	NULL
pC-luciferase	NULL
plasmid	NULL
(	NULL
52	NULL
)	NULL
of	NULL
the	NULL
Xhol-HindIII	NULL
fragment	NULL
of	NULL
the	NULL
HIV-1y	NULL
1a	NULL
;	NULL
LTR	NULL
from	NULL
the	NULL
original	NULL
construct	NULL
of	NULL
Leonard	NULL
et	NULL
al	NULL
.	NULL

with	NULL
the	NULL
two	NULL
«	NULL
B	NULL
motifs	NULL
deleted	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
CMV-tat	NULL
plasmid	NULL
carries	NULL
the	NULL
tat	NULL
cDNA	NULL
inserted	NULL
downstream	NULL
of	NULL
the	NULL
human	NULL
cytomegalovi-rus	NULL
(	NULL
CMV	NULL
)	NULL
immediate-early	NULL
enhancer/promoter	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
EF1-Bgal	NULL
construct	NULL
,	NULL
containing	NULL
the	NULL
B-galactosidase	NULL
reporter	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
basal	NULL
promoter	NULL
of	NULL
elongation	NULL
factor	NULL
EF1e	NULL
,	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
S.	NULL
Mémet	NULL
(	NULL
Pasteur	NULL
Institute	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
.	NULL

The	NULL
construct	NULL
IxBa-DN	NULL
,	NULL
carrying	NULL
the	NULL
cDNA	NULL
of	NULL
IxBa	NULL
protein	NULL
mutated	NULL
on	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
CMV	NULL
early	NULL
promoter	NULL
,	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
N.	NULL
Rice	NULL
(	NULL
63	NULL
)	NULL
.	NULL

ReCMV	NULL
(	NULL
Invitrogen	NULL
BV	NULL
)	NULL
was	NULL
the	NULL
corresponding	NULL
control	NULL
vector	NULL
which	NULL
contains	NULL
no	NULL
cDNA	NULL
sequence	NULL
.	NULL

Cells	NULL
and	NULL
culture	NULL
conditions	NULL
.	NULL

(	NULL
i	NULL
)	NULL
Isolation	NULL
of	NULL
enriched	NULL
human	NULL
populations	NULL
of	NULL
TEC	NULL
and	NULL
thymocytes	NULL
.	NULL

Fresh	NULL
thymus	NULL
fragments	NULL
were	NULL
obtained	NULL
during	NULL
elective	NULL
cardiac	NULL
surgery	NULL
on	NULL
HIV-1-seronegative	NULL
children	NULL
(	NULL
aged	NULL
6	NULL
days	NULL
to	NULL
24	NULL
months	NULL
)	NULL
.	NULL

The	NULL
enrichment	NULL
procedures	NULL
for	NULL
thymocytes	NULL
and	NULL
TEC	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
characterized	NULL
at	NULL
day	NULL
3	NULL
after	NULL
thymus	NULL
excision	NULL
,	NULL
using	NULL
different	NULL
selective	NULL
markers	NULL
(	NULL
with	NULL
the	NULL
various	NULL
antibodies	NULL
listed	NULL
above	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
populations	NULL
of	NULL
TEC	NULL
and	NULL
thymocytes	NULL
were	NULL
respectively	NULL
purified	NULL
at	NULL
95	NULL
and	NULL
99	NULL
%	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Prior	NULL
to	NULL
mixed	NULL
culture	NULL
,	NULL
TEC	NULL
were	NULL
maintained	NULL
in	NULL
a	NULL
selective	NULL
medium	NULL
(	NULL
McCoy	NULL
's	NULL
5A	NULL
[	NULL
GIBCO	NULL
]	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
[	NULL
FCS	NULL
]	NULL
,	NULL
1	NULL
mM	NULL
1-Glu	NULL
,	NULL
50	NULL
pg	NULL
of	NULL
penicillin-streptomycin	NULL
per	NULL
ml	NULL
,	NULL
100	NULL
ug	NULL
of	NULL
neomycin	NULL
per	NULL
ml	NULL
,	NULL
0.25	NULL
pg	NULL
of	NULL
Fun-gizone	NULL
per	NULL
ml	NULL
,	NULL
20	NULL
ng	NULL
of	NULL
epidermal	NULL
growth	NULL
factor	NULL
per	NULL
ml	NULL
,	NULL
5	NULL
X	NULL
10~°	NULL
M	NULL
cholera	NULL
toxin	NULL
,	NULL
500	NULL
ng	NULL
of	NULL
hydrocortisone	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
5	NULL
X	NULL
10~°	NULL
M	NULL
B-mercaptocethanol	NULL
)	NULL
.	NULL

Thymocytes	NULL
were	NULL
stored	NULL
at	NULL
+4°C	NULL
in	NULL
McCoy	NULL
's	NULL
5A	NULL
supplemented	NULL
with	NULL
antibiotics	NULL
,	NULL
L-glutamine	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
and	NULL
20	NULL
%	NULL
FCS	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
Mixed	NULL
culture	NULL
of	NULL
TEC	NULL
and	NULL
thymocytes	NULL
.	NULL

Autologous	NULL
or	NULL
heterologous	NULL
cocultures	NULL
of	NULL
TEC	NULL
and	NULL
infected	NULL
or	NULL
control	NULL
thymocytes	NULL
were	NULL
carried	NULL
out	NULL
3	NULL
days	NULL
after	NULL
thymic	NULL
excision	NULL
either	NULL
under	NULL
conditions	NULL
permitting	NULL
cell-to-cell	NULL
contact	NULL
or	NULL
in	NULL
transwell	NULL
chambers	NULL
(	NULL
0.45-um	NULL
pore	NULL
diameter	NULL
)	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
TEC	NULL
to	NULL
thymocytes	NULL
was	NULL
1/25	NULL
.	NULL

The	NULL
coculture	NULL
medium	NULL
was	NULL
McCoy	NULL
's	NULL
5A	NULL
supplemented	NULL
with	NULL
antibiotics	NULL
,	NULL
1	NULL
mM	NULL
1-glutamine	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
and	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

IL-6	NULL
and	NULL
GM-CSF	NULL
were	NULL
used	NULL
at	NULL
10	NULL
ng/ml	NULL
,	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
were	NULL
used	NULL
at	NULL
5	NULL
ng/ml	NULL
,	NULL
and	NULL
IL-7	NULL
was	NULL
used	NULL
at	NULL
1	NULL
ng/ml	NULL
.	NULL

MAb	NULL
against	NULL
IL-6	NULL
was	NULL
used	NULL
at	NULL
20	NULL
pg/ml	NULL
,	NULL
and	NULL
polyclonal	NULL
antibody	NULL
against	NULL
TNF	NULL
NF-	NULL
«	NULL
B-DEPENDENT	NULL
HIV-1	NULL
REPLICATION	NULL
IN	NULL
THYMUS	NULL
-	NULL
2065	NULL
was	NULL
used	NULL
at	NULL
a	NULL
serum	NULL
dilution	NULL
of	NULL
1/300	NULL
.	NULL

IL-1ra	NULL
was	NULL
used	NULL
at	NULL
20	NULL
ug/ml	NULL
.	NULL

Cytokines	NULL
or	NULL
cytokine	NULL
inhibitors	NULL
were	NULL
added	NULL
at	NULL
the	NULL
start	NULL
of	NULL
the	NULL
coculture	NULL
,	NULL
except	NULL
antibody	NULL
against	NULL
IL-7Re	NULL
.	NULL

The	NULL
thymocytes	NULL
were	NULL
preincubated	NULL
with	NULL
the	NULL
antibody	NULL
against	NULL
IL-7Ra	NULL
(	NULL
5	NULL
pg/ml	NULL
per	NULL
8	NULL
X	NULL
10°	NULL
thymocytes	NULL
)	NULL
for	NULL
6	NULL
h	NULL
at	NULL
4°C	NULL
before	NULL
their	NULL
coculture	NULL
with	NULL
TEC	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
the	NULL
thymocyte	NULL
culture	NULL
was	NULL
supplemented	NULL
with	NULL
50	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
noninfected	NULL
TEC	NULL
conditioned	NULL
medium	NULL
(	NULL
CM	NULL
)	NULL
obtained	NULL
after	NULL
72	NULL
h	NULL
of	NULL
TEC	NULL
culture	NULL
and	NULL
then	NULL
centrifuged	NULL
and	NULL
filtered	NULL
through	NULL
a	NULL
0.45-pm-pore-size	NULL
membrane	NULL
.	NULL

In	NULL
experiments	NULL
with	NULL
IL-7	NULL
antibody	NULL
,	NULL
TEC	NULL
CM	NULL
was	NULL
preincubated	NULL
for	NULL
6	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
the	NULL
antibody	NULL
per	NULL
ml	NULL
before	NULL
the	NULL
onset	NULL
of	NULL
thymocyte	NULL
culture	NULL
.	NULL

Immunostaining	NULL
and	NULL
cytofluorometry	NULL
.	NULL

Indirect	NULL
immunostaining	NULL
with	NULL
antibodies	NULL
against	NULL
cytokeratin	NULL
and	NULL
vimentin	NULL
was	NULL
performed	NULL
in	NULL
Lab-Tech	NULL
chambers	NULL
(	NULL
Corning	NULL
Costar	NULL
Corp.	NULL
,	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

on	NULL
cells	NULL
permeabilized	NULL
by	NULL
acetone-methanol	NULL
treatment	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Other	NULL
direct	NULL
or	NULL
indirect	NULL
immunostaining	NULL
was	NULL
analyzed	NULL
by	NULL
cytofluorometry	NULL
with	NULL
an	NULL
EPICS	NULL
Profile	NULL
II	NULL
fluorometer	NULL
(	NULL
Coulter	NULL
)	NULL
.	NULL

Virus	NULL
and	NULL
infection	NULL
procedure	NULL
.	NULL

HIV-1	NULL
,	NULL
,	NULL
,	NULL
and	NULL
HIV-1	NULL
,	NULL
.	NULL

;	NULL
.	NULL

,	NULL
,	NULL
...	NULL
.	NULL

were	NULL
obtained	NULL
after	NULL
transfection	NULL
of	NULL
Cos-7	NULL
cells	NULL
with	NULL
the	NULL
corresponding	NULL
provirus	NULL
constructs	NULL
(	NULL
4	NULL
)	NULL
by	NULL
using	NULL
standard	NULL
methods	NULL
with	NULL
Lipofectamine	NULL
(	NULL
GIBCO	NULL
)	NULL
.	NULL

HIV-1	NULL
,	NULL
,	NULL
,	NULL
was	NULL
obtained	NULL
after	NULL
transfection	NULL
of	NULL
the	NULL
entire	NULL
sequence	NULL
(	NULL
5'-3	NULL
'	NULL
)	NULL
of	NULL
the	NULL
molecular	NULL
clone	NULL
HIV-1	NULL
SF2	NULL
(	NULL
48	NULL
)	NULL
.	NULL

obtained	NULL
in	NULL
the	NULL
same	NULL
way	NULL
,	NULL
differed	NULL
from	NULL
the	NULL
wild-type	NULL
construct	NULL
by	NULL
having	NULL
a	NULL
5-bp	NULL
substitution	NULL
in	NULL
the	NULL
enhancer	NULL
region	NULL
of	NULL
the	NULL
viral	NULL
LTR	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
p24®	NULL
``	NULL
``	NULL
protein	NULL
was	NULL
determined	NULL
in	NULL
cell-free	NULL
supernatants	NULL
by	NULL
an	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELAVIA	NULL
;	NULL
Diagnostics	NULL
Pasteur	NULL
)	NULL
and	NULL
was	NULL
used	NULL
in	NULL
the	NULL
infection	NULL
procedure	NULL
immediately	NULL
.	NULL

All	NULL
infections	NULL
were	NULL
standardized	NULL
to	NULL
the	NULL
p24	NULL
levels	NULL
:	NULL
10	NULL
ng	NULL
of	NULL
p24	NULL
was	NULL
used	NULL
to	NULL
infect	NULL
10°	NULL
thymocytes	NULL
.	NULL

Briefly	NULL
,	NULL
thymocytes	NULL
were	NULL
washed	NULL
in	NULL
RPMI	NULL
and	NULL
exposed	NULL
either	NULL
to	NULL
HIV-1	NULL
,	NULL
,	NULL
,	NULL
Or	NULL
to	NULL
HIV	NULL
ig	NULL
my	NULL
;	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

After	NULL
infection	NULL
,	NULL
the	NULL
thymocytes	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
and	NULL
cultured	NULL
at	NULL
a	NULL
density	NULL
of	NULL
8	NULL
X	NULL
10°	NULL
per	NULL
well	NULL
(	NULL
12-well	NULL
plates	NULL
)	NULL
in	NULL
2	NULL
ml	NULL
of	NULL
medium	NULL
(	NULL
McCoy	NULL
's	NULL
5A	NULL
supplemented	NULL
with	NULL
antibiotics	NULL
,	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
1-Glu	NULL
)	NULL
or	NULL
cocultured	NULL
with	NULL
5	NULL
X	NULL
10°	NULL
TEC	NULL
.	NULL

On	NULL
days	NULL
6	NULL
,	NULL
8	NULL
,	NULL
11	NULL
,	NULL
13	NULL
,	NULL
15	NULL
,	NULL
and	NULL
18	NULL
after	NULL
the	NULL
start	NULL
of	NULL
the	NULL
coculture	NULL
,	NULL
300	NULL
pl	NULL
of	NULL
supernatant	NULL
were	NULL
collected	NULL
to	NULL
determine	NULL
the	NULL
p24®**	NULL
concentration	NULL
and	NULL
was	NULL
replaced	NULL
by	NULL
the	NULL
same	NULL
volume	NULL
of	NULL
fresh	NULL
medium	NULL
.	NULL

Transfection	NULL
procedure	NULL
.	NULL

Thymocytes	NULL
were	NULL
maintained	NULL
for	NULL
0	NULL
to	NULL
48	NULL
h	NULL
in	NULL
different	NULL
culture	NULL
or	NULL
coculture	NULL
conditions	NULL
prior	NULL
to	NULL
transfection	NULL
.	NULL

They	NULL
were	NULL
then	NULL
transfected	NULL
with	NULL
20	NULL
to	NULL
25	NULL
pg	NULL
of	NULL
plasmid	NULL
(	NULL
s	NULL
)	NULL
by	NULL
electroporation	NULL
in	NULL
MacCoy	NULL
's	NULL
5A	NULL
medium	NULL
with	NULL
20	NULL
%	NULL
FCS	NULL
.	NULL

A	NULL
single	NULL
pulse	NULL
at	NULL
875	NULL
V/cm	NULL
and	NULL
960	NULL
wF	NULL
was	NULL
performed	NULL
.	NULL

Expression	NULL
vectors	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
were	NULL
used	NULL
,	NULL
except	NULL
for	NULL
EF1-fgal	NULL
,	NULL
expressing	NULL
B-galactosidase	NULL
,	NULL
which	NULL
was	NULL
used	NULL
for	NULL
standardization	NULL
of	NULL
transfections	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
the	NULL
thymocytes	NULL
were	NULL
washed	NULL
and	NULL
were	NULL
then	NULL
returned	NULL
for	NULL
an	NULL
additional	NULL
20	NULL
h	NULL
to	NULL
the	NULL
previous	NULL
dishes	NULL
containing	NULL
the	NULL
conditioned	NULL
medium	NULL
of	NULL
48	NULL
h	NULL
of	NULL
culture	NULL
.	NULL

At	NULL
20	NULL
h	NULL
posttransfection	NULL
,	NULL
the	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
cell	NULL
lysates	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
by	NULL
standard	NULL
procedures	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
52	NULL
)	NULL
,	NULL
and	NULL
B-galactosidase	NULL
activity	NULL
was	NULL
measured	NULL
by	NULL
using	NULL
the	NULL
luminescent	NULL
B-galactosidase	NULL
genetic	NULL
reporter	NULL
system	NULL
II	NULL
(	NULL
Clon-tech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Normalized	NULL
luciferase	NULL
activity	NULL
represents	NULL
the	NULL
ratio	NULL
of	NULL
luciferase	NULL
to	NULL
B-galactosidase	NULL
activities	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Total	NULL
extracts	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
after	NULL
5	NULL
X	NULL
10°	NULL
to	NULL
10	NULL
X	NULL
10°	NULL
thymocytes	NULL
cultured	NULL
under	NULL
different	NULL
conditions	NULL
were	NULL
harvested	NULL
,	NULL
they	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
PBS	NULL
1	NULL
%	NULL
;	NULL
30	NULL
pl	NULL
of	NULL
lysis	NULL
buffer	NULL
was	NULL
added	NULL
,	NULL
centrifugation	NULL
(	NULL
13,220	NULL
%	NULL
g	NULL
for	NULL
10	NULL
min	NULL
)	NULL
was	NULL
performed	NULL
10	NULL
min	NULL
later	NULL
,	NULL
and	NULL
the	NULL
protein	NULL
concentration	NULL
in	NULL
the	NULL
supernatant	NULL
was	NULL
quantified	NULL
by	NULL
using	NULL
the	NULL
Bradford	NULL
reagent	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Ivry	NULL
sur	NULL
Seine	NULL
,	NULL
France	NULL
)	NULL
.	NULL

For	NULL
the	NULL
band	NULL
shift	NULL
assay	NULL
,	NULL
the	NULL
binding-reaction	NULL
mixture	NULL
was	NULL
prepared	NULL
by	NULL
adding	NULL
,	NULL
in	NULL
the	NULL
following	NULL
order	NULL
,	NULL
binding	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
2	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
60	NULL
mM	NULL
KCl	NULL
,	NULL
0.01	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
0.1	NULL
mg	NULL
of	NULL
bovine	NULL
serum	NULL
albu-min/ml	NULL
,	NULL
4	NULL
%	NULL
Ficoll	NULL
)	NULL
,	NULL
0.4	NULL
pg	NULL
of	NULL
sonicated	NULL
salmon	NULL
sperm	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
protein	NULL
extract	NULL
,	NULL
and	NULL
30,000	NULL
cpm	NULL
of	NULL
°°P-labelled	NULL
DNA	NULL
probe	NULL
corresponding	NULL
to	NULL
0.25	NULL
ng	NULL
of	NULL
probe	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
oligonucleotide	NULL
used	NULL
is	NULL
:	NULL
5°	NULL
CTAGACGGGGATTTCCGAGAGGT	NULL
TGCCCCTAAAGGCTCTICCAGATC	NULL
5	NULL
'	NULL
The	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
binding	NULL
sequence	NULL
is	NULL
in	NULL
boldface	NULL
type	NULL
.	NULL

Specific	NULL
binding	NULL
was	NULL
controlled	NULL
by	NULL
competition	NULL
with	NULL
a	NULL
40-fold	NULL
(	NULL
10-ng	NULL
)	NULL
excess	NULL
of	NULL
the	NULL
same	NULL
nonlabeled	NULL
oligonucleotide	NULL
,	NULL
added	NULL
to	NULL
the	NULL
protein	NULL
extract	NULL
before	NULL
the	NULL
binding	NULL
reaction	NULL
was	NULL
started	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
subunits	NULL
constituting	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
,	NULL
specific	NULL
antibodies	NULL
against	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
ReIB	NULL
were	NULL
used	NULL
.	NULL

The	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
antibodies	NULL
were	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
A	NULL
.	NULL

(	NULL
Pasteur	NULL
Institute	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
,	NULL
and	NULL
anti-ReIB	NULL
was	NULL
provided	NULL
by	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Antibodies	NULL
were	NULL
added	NULL
to	NULL
the	NULL
protein	NULL
extract	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
allowed	NULL
to	NULL
stand	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4°C	NULL
before	NULL
incubation	NULL
with	NULL
the	NULL
radiolabeled	NULL
probe	NULL
.	NULL

RESULTS	NULL
Coculture-induced	NULL
activation	NULL
of	NULL
HIV	NULL
replication	NULL
requires	NULL
the	NULL
two	NULL
B	NULL
sites	NULL
within	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
evaluate	NULL
the	NULL
relevance	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
HIV-1	NULL
replication	NULL
in	NULL
thymocytes	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
replication	NULL
capacity	NULL
of	NULL
a	NULL
virus	NULL
mutated	NULL
in	NULL
the	NULL
two	NULL
xB	NULL
sites	NULL
within	NULL
the	NULL
LTR	NULL
(	NULL
4	NULL
,	NULL
18	NULL
)	NULL
with	NULL
that	NULL
of	NULL
the	NULL
corresponding	NULL
wild-type	NULL
virus	NULL
.	NULL

Wild-type	NULL
and	NULL
2066	NULL
CHENE	NULL
ET	NULL
AL	NULL
.	NULL

8	NULL
ay	NULL
€	NULL
``	NULL
Ep	NULL
E	NULL
6	NULL
.-a	NULL
-S	NULL
LS	NULL
g	NULL
~-	NULL
@	NULL
--	NULL
_	NULL
Thym	NULL
.	NULL

wt	NULL
n	NULL
w	NULL
$	NULL
4	NULL
-	NULL
&	NULL
-	NULL
_	NULL
Thym	NULL
.	NULL

wt/TEC	NULL
&	NULL
S	NULL
--	NULL
-	NULL
-	NULL
Thym	NULL
.	NULL

xB-mut	NULL
B0	NULL
$	NULL
2	NULL
..	NULL
-O-	NULL
Thym	NULL
.	NULL

«	NULL
B-mut	NULL
/	NULL
TEC	NULL
e	NULL
G	NULL
0	NULL
6	NULL
9	NULL
12	NULL
15	NULL
18	NULL
days	NULL
post-infection	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Coculture-induced	NULL
activation	NULL
of	NULL
HIV	NULL
replication	NULL
requires	NULL
the	NULL
two	NULL
xB	NULL
sites	NULL
within	NULL
the	NULL
HIV	NULL
LTR	NULL
.	NULL

Freshly	NULL
isolated	NULL
thymocytes	NULL
were	NULL
infected	NULL
with	NULL
viral	NULL
supernatants	NULL
produced	NULL
after	NULL
48	NULL
h	NULL
of	NULL
culture	NULL
of	NULL
either	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
or	NULL
«	NULL
B-mut	NULL
proviral	NULL
DNA-transfected	NULL
Cos-7	NULL
cells	NULL
.	NULL

Infected	NULL
thymocytes	NULL
were	NULL
cultured	NULL
alone	NULL
(	NULL
Thym	NULL
.	NULL

wt	NULL
or	NULL
Thym	NULL
.	NULL

«	NULL
B-mut	NULL
)	NULL
or	NULL
cocultured	NULL
with	NULL
TEC	NULL
(	NULL
Thym	NULL
.	NULL

wi/TEC	NULL
or	NULL
Thym	NULL
.	NULL

«	NULL
B-mut/TEC	NULL
)	NULL
.	NULL

Viral	NULL
replication	NULL
was	NULL
determined	NULL
at	NULL
various	NULL
times	NULL
postinfection	NULL
by	NULL
the	NULL
detection	NULL
of	NULL
p24	NULL
antigen	NULL
in	NULL
the	NULL
thymocyte	NULL
culture	NULL
or	NULL
in	NULL
the	NULL
coculture	NULL
medium	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
here	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
each	NULL
carried	NULL
out	NULL
on	NULL
a	NULL
different	NULL
three	NULL
thymus	NULL
.	NULL

mutated	NULL
(	NULL
AB	NULL
)	NULL
viruses	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
supernatant	NULL
of	NULL
Cos-7	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
corresponding	NULL
provirus	NULL
constructs	NULL
.	NULL

We	NULL
then	NULL
carried	NULL
out	NULL
infection	NULL
of	NULL
thymocytes	NULL
and	NULL
cocultured	NULL
them	NULL
with	NULL
TEC	NULL
under	NULL
conditions	NULL
previously	NULL
described	NULL
by	NULL
Rothe	NULL
et	NULL
al	NULL
.	NULL

(	NULL
48	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
the	NULL
AB	NULL
virus	NULL
is	NULL
unable	NULL
to	NULL
replicate	NULL
in	NULL
thymocytes	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TEC	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
wild-type	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
is	NULL
required	NULL
for	NULL
HIV	NULL
replication	NULL
in	NULL
thymocytes	NULL
and	NULL
that	NULL
this	NULL
activation	NULL
is	NULL
provided	NULL
by	NULL
their	NULL
interaction	NULL
with	NULL
TEC	NULL
.	NULL

Interaction	NULL
with	NULL
TEC	NULL
permanently	NULL
induces	NULL
NF-KB	NULL
activity	NULL
in	NULL
thymocytes	NULL
.	NULL

We	NULL
then	NULL
determined	NULL
whether	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
present	NULL
in	NULL
the	NULL
human	NULL
thymus	NULL
as	NULL
a	NULL
whole	NULL
by	NULL
performing	NULL
EMSAs	NULL
with	NULL
protein	NULL
extract	NULL
from	NULL
a	NULL
thymus	NULL
fragment	NULL
immediately	NULL
crushed	NULL
after	NULL
surgery	NULL
and	NULL
a	NULL
probe	NULL
representing	NULL
the	NULL
HIV-1	NULL
LTR	NULL
«	NULL
B-derived	NULL
motifs	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
(	NULL
lane	NULL
2	NULL
[	NULL
control	NULL
]	NULL
)	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
specific	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
in	NULL
this	NULL
whole-cell	NULL
extract	NULL
.	NULL

This	NULL
activity	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
whole-cell	NULL
extracts	NULL
from	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
(	NULL
lane	NULL
4	NULL
[	NULL
control	NULL
]	NULL
]	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
,	NULL
observed	NULL
in	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
,	NULL
was	NULL
very	NULL
probably	NULL
present	NULL
in	NULL
these	NULL
cells	NULL
within	NULL
the	NULL
thymus	NULL
(	NULL
since	NULL
it	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
the	NULL
thymus	NULL
as	NULL
a	NULL
whole	NULL
)	NULL
and	NULL
was	NULL
not	NULL
induced	NULL
by	NULL
the	NULL
enrichment	NULL
procedure	NULL
used	NULL
for	NULL
these	NULL
cells	NULL
.	NULL

The	NULL
NF-kB	NULL
activity	NULL
represented	NULL
specific	NULL
DNA	NULL
binding	NULL
activities	NULL
since	NULL
they	NULL
were	NULL
competed	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
a	NULL
nonradiolabeled	NULL
kB	NULL
probe	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
.	NULL

This	NULL
NF-kB	NULL
activity	NULL
decreased	NULL
progressively	NULL
when	NULL
thymocytes	NULL
were	NULL
cultured	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
this	NULL
decrease	NULL
in	NULL
culture	NULL
varies	NULL
according	NULL
to	NULL
the	NULL
different	NULL
preparations	NULL
of	NULL
thymocytes	NULL
obtained	NULL
from	NULL
different	NULL
thymuses	NULL
.	NULL

The	NULL
minimal	NULL
levels	NULL
were	NULL
observed	NULL
at	NULL
between	NULL
24	NULL
and	NULL
48	NULL
h	NULL
of	NULL
culture	NULL
.	NULL

In	NULL
any	NULL
case	NULL
,	NULL
this	NULL
activity	NULL
was	NULL
maintained	NULL
when	NULL
thymocytes	NULL
were	NULL
cocultivated	NULL
with	NULL
autologous	NULL
TEC	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

The	NULL
same	NULL
result	NULL
was	NULL
obtained	NULL
with	NULL
either	NULL
autologous	NULL
(	NULL
from	NULL
3	NULL
thymuses	NULL
)	NULL
or	NULL
heterologous	NULL
(	NULL
from	NULL
10	NULL
thymuses	NULL
)	NULL
TEC	NULL
,	NULL
indicating	NULL
that	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
did	NULL
not	NULL
result	NULL
from	NULL
cellular	NULL
activation	NULL
caused	NULL
by	NULL
a	NULL
mixed	NULL
lymphocyte	NULL
reaction	NULL
but	NULL
was	NULL
due	NULL
J.	NULL
Virou	NULL
.	NULL

Thymocytes	NULL
Whole	NULL
thymus	NULL
total	NULL
extract	NULL
_	NULL
Freshly	NULL
Cultured	NULL
__	NULL
Cocultured	NULL
isolated	NULL
alone	NULL
with	NULL
TEC	NULL
+d	NULL
+d	NULL
&	NULL
&	NULL
a	NULL
8	NULL
£0	NULL
5	NULL
§	NULL
8	NULL
§	NULL
5	NULL
%	NULL
E	NULL
®	NULL
E	NULL
.|	NULL
'	NULL
'	NULL
a-nrFr-B	NULL
a	NULL
|	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
so	NULL
P	NULL
3	NULL
8	NULL
%	NULL
s	NULL
ea	NULL
m	NULL
-	NULL
&	NULL
2	NULL
B	NULL
5	NULL
§	NULL
R	NULL
%	NULL
%	NULL
%	NULL
%	NULL
&	NULL
p50-65	NULL
50-ReIB	NULL
Whole	NULL
thymus	NULL
.	NULL

.	NULL

.	NULL

.	NULL

..	NULL
P	NULL
e	NULL
.	NULL

<	NULL
G-p50-50	NULL
+	NULL
pall	NULL
pl	NULL
a	NULL
»	NULL
|	NULL
<	NULL
-n.s	NULL
1	NULL
I	NULL
p50-65	NULL
p50-RelB	NULL
mu	NULL
|	NULL
WW	NULL
Wont	NULL
thymocytes	NULL
p50-50	NULL
p50-65	NULL
Thymocytes	NULL
we	NULL
'	NULL
'	NULL
r	NULL
p50-RelB	NULL
cocultured	NULL
with	NULL
TEC	NULL
f	NULL
<	NULL
4-ps0-50	NULL
.	NULL

#	NULL
®	NULL
t	NULL
for	NULL
70	NULL
hours	NULL
4	NULL
ns	NULL
1	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Interaction	NULL
of	NULL
thymocytes	NULL
with	NULL
TEC	NULL
leads	NULL
to	NULL
a	NULL
permanent	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
in	NULL
thymocytes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Protein	NULL
extracts	NULL
were	NULL
obtained	NULL
from	NULL
a	NULL
frozen	NULL
and	NULL
crushed	NULL
piece	NULL
of	NULL
thymus	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
from	NULL
thymocytes	NULL
freshly	NULL
isolated	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
cultured	NULL
for	NULL
30	NULL
h	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
to	NULL
70	NULL
h	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
or	NULL
cocultured	NULL
with	NULL
TEC	NULL
for	NULL
30	NULL
h	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
70	NULL
h	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

These	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
``	NULL
P-labeled	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
HIV	NULL
LTR-derived	NULL
«	NULL
B	NULL
motif	NULL
.	NULL

Competition	NULL
(	NULL
comp	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
with	NULL
a	NULL
40-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
was	NULL
used	NULL
to	NULL
confirm	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
detected	NULL
.	NULL

``	NULL
NF-xB	NULL
``	NULL
refers	NULL
to	NULL
several	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
,	NULL
which	NULL
are	NULL
further	NULL
analyzed	NULL
in	NULL
panel	NULL
B	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
3	NULL
independent	NULL
experiments	NULL
carried	NULL
out	NULL
with	NULL
autologous	NULL
TEC	NULL
on	NULL
three	NULL
thymuses	NULL
and	NULL
10	NULL
independent	NULL
experiments	NULL
carried	NULL
out	NULL
with	NULL
heterologous	NULL
TEC	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Identification	NULL
by	NULL
immunoreac-tivity	NULL
of	NULL
the	NULL
distinct	NULL
NF-kB	NULL
complexes	NULL
present	NULL
in	NULL
the	NULL
thymocytes	NULL
.	NULL

Protein	NULL
extracts	NULL
were	NULL
obtained	NULL
either	NULL
from	NULL
a	NULL
frozen	NULL
and	NULL
crushed	NULL
piece	NULL
of	NULL
thymus	NULL
or	NULL
from	NULL
whole-cell	NULL
extracts	NULL
of	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
or	NULL
of	NULL
thymocytes	NULL
cultured	NULL
for	NULL
70	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TEC	NULL
.	NULL

These	NULL
extracts	NULL
were	NULL
preincubated	NULL
with	NULL
preimmune	NULL
serum	NULL
(	NULL
preI	NULL
)	NULL
or	NULL
with	NULL
antisera	NULL
raised	NULL
against	NULL
distinct	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
:	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
or	NULL
RelB	NULL
(	NULL
as	NULL
indicated	NULL
above	NULL
the	NULL
lanes	NULL
)	NULL
before	NULL
incubation	NULL
with	NULL
the	NULL
labeled	NULL
probe	NULL
.	NULL

The	NULL
composition	NULL
of	NULL
the	NULL
complexes	NULL
is	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
each	NULL
carried	NULL
out	NULL
on	NULL
a	NULL
different	NULL
thymus	NULL
.	NULL

n.s	NULL
1	NULL
refers	NULL
to	NULL
a	NULL
nonspecific	NULL
binding	NULL
activity	NULL
since	NULL
it	NULL
was	NULL
not	NULL
competed	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
nonradiolabeled	NULL
xB	NULL
probe	NULL
.	NULL

to	NULL
physiological	NULL
interactions	NULL
between	NULL
thymocytes	NULL
and	NULL
TEC	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
coculture	NULL
with	NULL
TEC	NULL
induces	NULL
a	NULL
sustained	NULL
NF-KB	NULL
activation	NULL
in	NULL
thymocytes	NULL
.	NULL

We	NULL
then	NULL
characterized	NULL
the	NULL
NF-	NULL
«	NULL
xB	NULL
complexes	NULL
which	NULL
bind	NULL
to	NULL
the	NULL
HIV	NULL
enhancer	NULL
element	NULL
by	NULL
using	NULL
antibodies	NULL
against	NULL
each	NULL
subunit	NULL
of	NULL
the	NULL
NF-kB	NULL
family	NULL
(	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65	NULL
,	NULL
RelB	NULL
,	NULL
and	NULL
c-Rel	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
in	NULL
the	NULL
whole-thymus	NULL
extract	NULL
,	NULL
an	NULL
antibody	NULL
against	NULL
the	NULL
p50	NULL
subunit	NULL
abolished	NULL
the	NULL
binding	NULL
of	NULL
most	NULL
of	NULL
the	NULL
complexes	NULL
observed	NULL
,	NULL
an	NULL
antibody	NULL
against	NULL
p65	NULL
abolished	NULL
the	NULL
very	NULL
faint	NULL
band	NULL
corresponding	NULL
to	NULL
the	NULL
upper	NULL
complex	NULL
,	NULL
and	NULL
an	NULL
antibody	NULL
against	NULL
ReIB	NULL
abolished	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
upper	NULL
and	NULL
intermediate	NULL
complexes	NULL
.	NULL

The	NULL
antibody	NULL
against	NULL
c-Rel	NULL
did	NULL
not	NULL
significantly	NULL
modify	NULL
the	NULL
binding	NULL
of	NULL
any	NULL
of	NULL
these	NULL
complexes	NULL
.	NULL

voL	NULL
.	NULL

73	NULL
,	NULL
1999	NULL
48h	NULL
-	NULL
Time	NULL
of	NULL
preculture	NULL
of	NULL
thymocytes	NULL
wn	NULL
mn	NULL
umm	NULL
Ja	NULL
|	NULL
i	NULL
Coculture	NULL
with	NULL
TEC	NULL
A	NULL
0	NULL
B	NULL
me	NULL
tn	NULL
1	NULL
Normalized	NULL
luciferase	NULL
activity	NULL
2	NULL
T	NULL
H	NULL
H	NULL
0	NULL
cotransfected	NULL
LTR-uce	NULL
plasmids	NULL
:	NULL
_	NULL
O-	NULL
cmvre	NULL
--	NULL
A	NULL
EF1-figal	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
NF-kB	NULL
binding	NULL
activity	NULL
in	NULL
thymocytes	NULL
correlates	NULL
with	NULL
the	NULL
level	NULL
of	NULL
HIV-LTR	NULL
activity	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

2	NULL
in	NULL
whole-cell	NULL
extracts	NULL
from	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
or	NULL
thymocytes	NULL
cultured	NULL
alone	NULL
for	NULL
24	NULL
or	NULL
48	NULL
h	NULL
or	NULL
cocultured	NULL
with	NULL
TEC	NULL
for	NULL
48	NULL
h.	NULL
In	NULL
parallel	NULL
,	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
or	NULL
thymocytes	NULL
precultured	NULL
for	NULL
24	NULL
and	NULL
48	NULL
h	NULL
alone	NULL
or	NULL
with	NULL
TEC	NULL
were	NULL
cotransfected	NULL
by	NULL
electroporation	NULL
with	NULL
the	NULL
constructs	NULL
LTR-luc	NULL
,	NULL
CMV-Tat	NULL
,	NULL
EF1-Bgal	NULL
(	NULL
respectively	NULL
used	NULL
at	NULL
10	NULL
,	NULL
2.5	NULL
,	NULL
and	NULL
10	NULL
pg	NULL
per	NULL
10	NULL
``	NULL
cells	NULL
)	NULL
.	NULL

The	NULL
transfected	NULL
thymocytes	NULL
were	NULL
then	NULL
returned	NULL
to	NULL
the	NULL
previous	NULL
culture	NULL
conditions	NULL
for	NULL
20	NULL
h.	NULL
Luciferase	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
were	NULL
determined	NULL
20	NULL
h	NULL
after	NULL
transfection	NULL
in	NULL
the	NULL
thymocyte	NULL
lysates	NULL
.	NULL

LTR	NULL
activity	NULL
was	NULL
expressed	NULL
as	NULL
normalized	NULL
luciferase	NULL
activity	NULL
corresponding	NULL
to	NULL
the	NULL
ratio	NULL
of	NULL
luciferase	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
per	NULL
10°	NULL
cells	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
,	NULL
each	NULL
carried	NULL
out	NULL
on	NULL
a	NULL
different	NULL
thymus	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
lowest	NULL
complex	NULL
is	NULL
p50-p50	NULL
,	NULL
the	NULL
intermediate	NULL
and	NULL
major	NULL
complex	NULL
is	NULL
p50-RelB	NULL
,	NULL
and	NULL
the	NULL
upper	NULL
complex	NULL
probably	NULL
contains	NULL
p50	NULL
,	NULL
p52	NULL
(	NULL
as	NULL
a	NULL
minor	NULL
component	NULL
)	NULL
,	NULL
and	NULL
p65	NULL
.	NULL

As	NULL
also	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
in	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
p50-p65	NULL
was	NULL
the	NULL
prevalent	NULL
complex	NULL
,	NULL
and	NULL
coculture	NULL
with	NULL
TEC	NULL
maintained	NULL
this	NULL
complex	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
the	NULL
p50-RelB	NULL
one	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
NF-KB	NULL
binding	NULL
activity	NULL
in	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
or	NULL
in	NULL
thymocytes	NULL
cultured	NULL
with	NULL
TEC	NULL
is	NULL
responsible	NULL
for	NULL
a	NULL
high	NULL
HIV-1	NULL
LTR	NULL
activity	NULL
.	NULL

We	NULL
then	NULL
determined	NULL
whether	NULL
the	NULL
sustained	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
observed	NULL
in	NULL
thymocytes	NULL
,	NULL
either	NULL
freshly	NULL
isolated	NULL
or	NULL
cocultured	NULL
with	NULL
TEC	NULL
,	NULL
correlated	NULL
with	NULL
the	NULL
level	NULL
of	NULL
LTR	NULL
activity	NULL
in	NULL
thymocytes	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
de-termined	NULL
,	NULL
in	NULL
parallel	NULL
experiments	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
and	NULL
the	NULL
level	NULL
of	NULL
luciferase	NULL
activity	NULL
of	NULL
the	NULL
LTR-lue	NULL
construct	NULL
transfected	NULL
in	NULL
thymocytes	NULL
.	NULL

A	NULL
CMV	NULL
-tat	NULL
construct	NULL
was	NULL
cotransfected	NULL
with	NULL
LTR-luc	NULL
since	NULL
expression	NULL
of	NULL
the	NULL
powerful	NULL
viral	NULL
transactivator	NULL
Tat	NULL
emphasizes	NULL
the	NULL
magnitude	NULL
of	NULL
NF-	NULL
«	NULL
xB-depen-dent	NULL
transactivation	NULL
of	NULL
the	NULL
LTR	NULL
(	NULL
15	NULL
)	NULL
.	NULL

EF1-Bgal	NULL
plasmid	NULL
containing	NULL
the	NULL
reporter	NULL
gene	NULL
B-galactosidase	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
basal	NULL
promoter	NULL
of	NULL
the	NULL
elongation	NULL
factor	NULL
EFla	NULL
was	NULL
also	NULL
cotransfected	NULL
to	NULL
normalize	NULL
the	NULL
transfection	NULL
efficiencies	NULL
.	NULL

Thymocytes	NULL
were	NULL
cultured	NULL
alone	NULL
or	NULL
cocultured	NULL
with	NULL
TEC	NULL
for	NULL
48	NULL
h	NULL
prior	NULL
to	NULL
cotransfection	NULL
by	NULL
electroporation	NULL
with	NULL
LTR-luc	NULL
,	NULL
CMV	NULL
-tat	NULL
,	NULL
and	NULL
EF1-Bgal	NULL
.	NULL

The	NULL
thymocytes	NULL
were	NULL
collected	NULL
from	NULL
the	NULL
culture	NULL
dishes	NULL
(	NULL
then	NULL
containing	NULL
a	NULL
48-h	NULL
conditioned	NULL
me-dium	NULL
)	NULL
for	NULL
the	NULL
time	NULL
of	NULL
electroporation	NULL
and	NULL
were	NULL
then	NULL
returned	NULL
to	NULL
this	NULL
conditioned	NULL
medium	NULL
for	NULL
an	NULL
additional	NULL
20	NULL
h.	NULL
LTR	NULL
activity	NULL
,	NULL
expressed	NULL
as	NULL
normalized	NULL
luciferase	NULL
activity	NULL
,	NULL
was	NULL
then	NULL
deter-mined	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
LTR	NULL
activity	NULL
correlated	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B-DEPENDENT	NULL
HIV-1	NULL
REPLICATION	NULL
IN	NULL
THYMUS	NULL
-	NULL
2067	NULL
level	NULL
of	NULL
NF-kB	NULL
binding	NULL
activity	NULL
.	NULL

LTR	NULL
activity	NULL
was	NULL
high	NULL
in	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
and	NULL
progressively	NULL
decreased	NULL
(	NULL
for	NULL
24	NULL
or	NULL
48	NULL
h	NULL
)	NULL
when	NULL
these	NULL
cells	NULL
were	NULL
cultured	NULL
alone	NULL
,	NULL
whereas	NULL
it	NULL
was	NULL
maintained	NULL
at	NULL
a	NULL
high	NULL
level	NULL
in	NULL
those	NULL
cocultivated	NULL
with	NULL
TEC	NULL
(	NULL
for	NULL
48	NULL
h	NULL
)	NULL
.	NULL

However	NULL
,	NULL
whereas	NULL
NF-KB	NULL
binding	NULL
activity	NULL
was	NULL
higher	NULL
in	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
than	NULL
in	NULL
thymocytes	NULL
cocultivated	NULL
with	NULL
TEC	NULL
,	NULL
LTR	NULL
activity	NULL
was	NULL
comparable	NULL
in	NULL
the	NULL
two	NULL
cell	NULL
systems	NULL
.	NULL

This	NULL
can	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
NF-xB	NULL
activity	NULL
was	NULL
determined	NULL
just	NULL
after	NULL
thymocyte	NULL
isolation	NULL
whereas	NULL
the	NULL
luciferase	NULL
assay	NULL
was	NULL
performed	NULL
20	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

This	NULL
interval	NULL
is	NULL
sufficient	NULL
to	NULL
allow	NULL
a	NULL
significant	NULL
decrease	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TEC	NULL
.	NULL

We	NULL
then	NULL
confirmed	NULL
that	NULL
the	NULL
xB	NULL
sites	NULL
were	NULL
required	NULL
for	NULL
the	NULL
high	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
LTR	NULL
in	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
or	NULL
in	NULL
thymocytes	NULL
in	NULL
coculture	NULL
with	NULL
TEC	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
an	NULL
LTR-A	NULL
«	NULL
B	NULL
mutated	NULL
in	NULL
the	NULL
two	NULL
kB	NULL
sites	NULL
was	NULL
5-	NULL
to	NULL
10-fold	NULL
lower	NULL
than	NULL
that	NULL
observed	NULL
with	NULL
the	NULL
wild-type	NULL
LTR	NULL
construct	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
«	NULL
B-responsive	NULL
element	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
comparing	NULL
the	NULL
luciferase	NULL
activity	NULL
obtained	NULL
with	NULL
the	NULL
3Enh-TK-luc	NULL
construct	NULL
to	NULL
that	NULL
obtained	NULL
with	NULL
the	NULL
control	NULL
vector	NULL
TK-luc	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
a	NULL
10-	NULL
to	NULL
15-fold	NULL
difference	NULL
was	NULL
observed	NULL
between	NULL
the	NULL
two	NULL
constructs	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
formally	NULL
demonstrated	NULL
that	NULL
NF-kB	NULL
was	NULL
specifically	NULL
responsible	NULL
for	NULL
transactivation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
by	NULL
cotransfecting	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
with	NULL
LTR-luc	NULL
,	NULL
CMV-tat	NULL
,	NULL
and	NULL
an	NULL
expression	NULL
vector	NULL
encoding	NULL
the	NULL
IxBa	NULL
inhibitory	NULL
protein	NULL
mutated	NULL
on	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
(	NULL
IxBa	NULL
«	NULL
-DN	NULL
)	NULL
(	NULL
63	NULL
)	NULL
.	NULL

These	NULL
mutations	NULL
prevent	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

IxBa-DN	NULL
behaves	NULL
as	NULL
a	NULL
specific	NULL
and	NULL
constitutive	NULL
inhibitor	NULL
of	NULL
NF-kB	NULL
activity	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
we	NULL
replaced	NULL
IxBa-DN	NULL
by	NULL
the	NULL
vector	NULL
RecCMV	NULL
.	NULL

Indeed	NULL
,	NULL
cotransfection	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
this	NULL
mutant	NULL
progressively	NULL
reduced	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
LTR	NULL
to	NULL
a	NULL
value	NULL
comparable	NULL
to	NULL
that	NULL
obtained	NULL
with	NULL
the	NULL
LTR-AkB	NULL
in	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
as	NULL
well	NULL
as	NULL
in	NULL
thymocytes	NULL
cocultured	NULL
with	NULL
TEC	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
IxBa-DN	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
LTR-AkB	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
,	NULL
confirming	NULL
against	NULL
that	NULL
it	NULL
specifically	NULL
targets	NULL
NF-kB	NULL
on	NULL
the	NULL
wild-type	NULL
LTR	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
experiments	NULL
provide	NULL
evidence	NULL
of	NULL
a	NULL
permanent	NULL
induction	NULL
of	NULL
activity	NULL
leading	NULL
to	NULL
a	NULL
permanent	NULL
LTR	NULL
transactivation	NULL
in	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
or	NULL
in	NULL
thymocytes	NULL
cocultured	NULL
with	NULL
TEC	NULL
.	NULL

NF-B	NULL
activation	NULL
induced	NULL
by	NULL
the	NULL
interaction	NULL
of	NULL
thymocytes	NULL
with	NULL
TEC	NULL
is	NULL
mediated	NULL
mainly	NULL
by	NULL
TNF	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
by	NULL
IL-1	NULL
,	NULL
but	NULL
NF-B	NULL
inducibility	NULL
requires	NULL
IL-7	NULL
.	NULL

TNF	NULL
and	NULL
IL-1	NULL
are	NULL
well-known	NULL
triggers	NULL
of	NULL
NF-KB	NULL
activation	NULL
(	NULL
10	NULL
,	NULL
26	NULL
,	NULL
44	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
the	NULL
strong	NULL
activation	NULL
of	NULL
HIV	NULL
replication	NULL
in	NULL
thymocytes	NULL
,	NULL
elicited	NULL
by	NULL
their	NULL
interaction	NULL
with	NULL
TEC	NULL
,	NULL
is	NULL
mediated	NULL
mainly	NULL
by	NULL
soluble	NULL
factors	NULL
including	NULL
IL-1	NULL
,	NULL
TNF	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
GM-CSF	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
first	NULL
evaluated	NULL
whether	NULL
these	NULL
cytokines	NULL
,	NULL
particularly	NULL
IL-1	NULL
and	NULL
TNF	NULL
,	NULL
were	NULL
involved	NULL
in	NULL
the	NULL
permanent	NULL
induction	NULL
of	NULL
NF-kB	NULL
observed	NULL
in	NULL
thymocytes	NULL
cocultured	NULL
with	NULL
TEC	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
performed	NULL
cocultures	NULL
in	NULL
transwell	NULL
chambers	NULL
to	NULL
prevent	NULL
cell-to-cell	NULL
contact	NULL
but	NULL
to	NULL
allow	NULL
the	NULL
exchange	NULL
of	NULL
soluble	NULL
factors	NULL
.	NULL

At	NULL
the	NULL
start	NULL
of	NULL
the	NULL
coculture	NULL
,	NULL
neutralizing	NULL
antibodies	NULL
against	NULL
IL-1	NULL
and	NULL
TNF	NULL
were	NULL
added	NULL
to	NULL
test	NULL
their	NULL
ability	NULL
to	NULL
block	NULL
NF-kB	NULL
activation	NULL
.	NULL

An	NULL
antagonist	NULL
of	NULL
the	NULL
IL-1	NULL
receptor	NULL
(	NULL
IL-1ra	NULL
)	NULL
was	NULL
also	NULL
used	NULL
.	NULL

A	NULL
neutralizing	NULL
antibody	NULL
against	NULL
IL-6	NULL
was	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
,	NULL
since	NULL
IL-6	NULL
is	NULL
not	NULL
an	NULL
inducer	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
NF-kB	NULL
activation	NULL
was	NULL
sustained	NULL
by	NULL
the	NULL
coculture	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cell-to-cell	NULL
contact	NULL
,	NULL
indicating	NULL
that	NULL
soluble	NULL
factors	NULL
were	NULL
mainly	NULL
involved	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
antibody	NULL
against	NULL
IL-6	NULL
did	NULL
not	NULL
reduce	NULL
NF-kB	NULL
2068	NULL
CHENE	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
B	NULL
r	NULL
3	NULL
1547	NULL
304	NULL
10	NULL
4	NULL
204	NULL
107	NULL
Normalized	NULL
luciferase	NULL
activity	NULL
Normalized	NULL
luciferase	NULL
activity	NULL
Lie	NULL
0	NULL
7	NULL
LTR-lue	NULL
-	NULL
LTRAxB-lue	NULL
3Enh-TK-lue	NULL
-	NULL
TK-luc	NULL
CMV	NULL
-tat	NULL
CMV-tat	NULL
EF1-fgal	NULL
_	NULL
EF1-fgal	NULL
EFL-Bgal	NULL
J.	NULL
Virou	NULL
.	NULL

C	NULL
D	NULL
257	NULL
[	NULL
3	NULL
E	NULL
Z	NULL
.	NULL

>	NULL
g	NULL
204	NULL
‘	NULL
g	NULL
20	NULL
=	NULL
9	NULL
t	NULL
¥	NULL
w	NULL
§	NULL
is-	NULL
§	NULL
_	NULL
is	NULL
&	NULL
Us	NULL
€	NULL
S2	NULL
2	NULL
34	NULL
``	NULL
a	NULL
105	NULL
``	NULL
I	NULL
16	NULL
.	NULL

``	NULL
G	NULL
c	NULL
3	NULL
%	NULL
3	NULL
%	NULL
ol	NULL
=	NULL
Z	NULL
2	NULL
a	NULL
-	NULL
0	NULL
LTR-luc	NULL
(	NULL
ng	NULL
)	NULL
_	NULL
6	NULL
6	NULL
6	NULL
LTRAxB-luc	NULL
(	NULL
ug	NULL
)	NULL
6	NULL
6	NULL
IxBo-DN	NULL
(	NULL
g	NULL
)	NULL
-	NULL
0	NULL
6	NULL
12	NULL
IxBo-DN	NULL
(	NULL
ug	NULL
)	NULL
0	NULL
12	NULL
EF1-fgal	NULL
6	NULL
6	NULL
6	NULL
EF1-figal	NULL
6	NULL
6	NULL
CMV-tat	NULL
(	NULL
ug	NULL
)	NULL
_	NULL
2	NULL
2	NULL
2	NULL
CMV	NULL
-tat	NULL
(	NULL
ug	NULL
)	NULL
2	NULL
2	NULL
ReCMVing	NULL
)	NULL
-	NULL
12	NULL
6	NULL
0	NULL
ReCMV	NULL
(	NULL
ug	NULL
)	NULL
12	NULL
0	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activity	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
high	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
LTR	NULL
in	NULL
thymocytes	NULL
freshly	NULL
isolated	NULL
or	NULL
cocultured	NULL
with	NULL
TEC	NULL
.	NULL

Freshly	NULL
isolated	NULL
thymocytes	NULL
were	NULL
cotransfected	NULL
by	NULL
electroporation	NULL
with	NULL
the	NULL
following	NULL
constructs	NULL
:	NULL
LTRIuc	NULL
,	NULL
CMV-tat	NULL
,	NULL
and	NULL
EF1-fBgal	NULL
(	NULL
respectively	NULL
used	NULL
at	NULL
10	NULL
,	NULL
5	NULL
,	NULL
and	NULL
10	NULL
pg	NULL
per	NULL
10	NULL
``	NULL
cells	NULL
)	NULL
or	NULL
LTR-A	NULL
«	NULL
B-lue	NULL
,	NULL
CMV-tat	NULL
,	NULL
and	NULL
EF1-Bgal	NULL
(	NULL
used	NULL
at	NULL
10	NULL
,	NULL
5	NULL
,	NULL
and	NULL
10	NULL
pg	NULL
per	NULL
10	NULL
``	NULL
cells	NULL
)	NULL
(	NULL
A	NULL
)	NULL
;	NULL
3Enh-TK-lue	NULL
and	NULL
EF1-fgal	NULL
(	NULL
each	NULL
used	NULL
at	NULL
10pg	NULL
per	NULL
10	NULL
``	NULL
cells	NULL
)	NULL
or	NULL
TK-lue	NULL
and	NULL
EF1-Bgal	NULL
(	NULL
used	NULL
at	NULL
10	NULL
and	NULL
10	NULL
pg	NULL
per	NULL
10	NULL
``	NULL
cells	NULL
)	NULL
(	NULL
B	NULL
)	NULL
;	NULL
LTRluc	NULL
,	NULL
CMV-tat	NULL
,	NULL
and	NULL
EF1-Bgal	NULL
(	NULL
used	NULL
at	NULL
6	NULL
,	NULL
2	NULL
,	NULL
and	NULL
6	NULL
ug	NULL
per	NULL
10	NULL
``	NULL
cells	NULL
)	NULL
and	NULL
increasing	NULL
amounts	NULL
of	NULL
I	NULL
«	NULL
Ba-DN	NULL
expression	NULL
vector	NULL
as	NULL
indicated	NULL
(	NULL
C	NULL
)	NULL
;	NULL
and	NULL
LTR-A	NULL
«	NULL
B-luc	NULL
,	NULL
CMV-tat	NULL
,	NULL
and	NULL
EF1-Bgal	NULL
(	NULL
used	NULL
at	NULL
6	NULL
,	NULL
2	NULL
,	NULL
and	NULL
6	NULL
ug	NULL
per	NULL
10	NULL
``	NULL
cells	NULL
)	NULL
and	NULL
12	NULL
pg	NULL
of	NULL
IxB	NULL
«	NULL
-DN	NULL
expression	NULL
vector	NULL
as	NULL
indicated	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Re-CMV	NULL
was	NULL
added	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
to	NULL
normalize	NULL
the	NULL
amount	NULL
of	NULL
transfected	NULL
DNA	NULL
.	NULL

Luciferase	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
were	NULL
determined	NULL
20	NULL
h	NULL
after	NULL
transfection	NULL
in	NULL
the	NULL
thymocyte	NULL
lysates	NULL
.	NULL

LTR	NULL
activity	NULL
was	NULL
expressed	NULL
as	NULL
normalized	NULL
luciferase	NULL
activity	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
each	NULL
carried	NULL
out	NULL
on	NULL
a	NULL
different	NULL
thymus	NULL
.	NULL

activation	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
IL-1ra	NULL
or	NULL
antibody	NULL
against	NULL
IL-18	NULL
were	NULL
very	NULL
modest	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
anti-TNF	NULL
almost	NULL
completely	NULL
abolished	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
thymocytes	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
the	NULL
extent	NULL
of	NULL
inhibition	NULL
was	NULL
about	NULL
the	NULL
same	NULL
with	NULL
anti-TNF	NULL
as	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
anti-TNF	NULL
,	NULL
IL-1ra	NULL
,	NULL
and	NULL
anti-IL-6	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
cell-to-cell	NULL
contact	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
11	NULL
)	NULL
strongly	NULL
suggests	NULL
that	NULL
TNF	NULL
is	NULL
the	NULL
major	NULL
inducer	NULL
of	NULL
NF-kB	NULL
activation	NULL
within	NULL
the	NULL
coculture	NULL
.	NULL

We	NULL
then	NULL
tested	NULL
whether	NULL
TNF	NULL
or	NULL
IL-1B	NULL
was	NULL
sufficient	NULL
to	NULL
induce	NULL
NF-kB	NULL
binding	NULL
activity	NULL
in	NULL
thymocytes	NULL
cultured	NULL
alone	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
IL-1B	NULL
had	NULL
a	NULL
weak	NULL
stimulating	NULL
effect	NULL
on	NULL
NF-kB	NULL
activity	NULL
in	NULL
thymocytes	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
TNF	NULL
,	NULL
which	NULL
was	NULL
able	NULL
by	NULL
itself	NULL
to	NULL
sustain	NULL
a	NULL
high	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
thymocytes	NULL
cultured	NULL
for	NULL
30	NULL
h	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
level	NULL
of	NULL
NF-kB	NULL
activity	NULL
obtained	NULL
with	NULL
TNF	NULL
was	NULL
lower	NULL
than	NULL
that	NULL
observed	NULL
in	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
(	NULL
compare	NULL
lane	NULL
3	NULL
to	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
TNF	NULL
was	NULL
not	NULL
efficient	NULL
in	NULL
maintaining	NULL
long-term	NULL
(	NULL
for	NULL
instance	NULL
,	NULL
60-h	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
other	NULL
factors	NULL
within	NULL
the	NULL
microenvironment	NULL
might	NULL
be	NULL
required	NULL
to	NULL
maintain	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
thymocytes	NULL
.	NULL

This	NULL
hypothesis	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
TEC	NULL
CM	NULL
,	NULL
when	NULL
supplemented	NULL
with	NULL
TNF	NULL
,	NULL
was	NULL
able	NULL
to	NULL
maintain	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
for	NULL
60	NULL
h	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
whereas	NULL
TEC	NULL
CM	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
TNF	NULL
is	NULL
mainly	NULL
required	NULL
to	NULL
maintain	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
thymocytes	NULL
but	NULL
that	NULL
its	NULL
effect	NULL
requires	NULL
another	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
secreted	NULL
by	NULL
TEC	NULL
.	NULL

We	NULL
tested	NULL
the	NULL
possibility	NULL
that	NULL
IL-7	NULL
,	NULL
a	NULL
cytokine	NULL
expressed	NULL
by	NULL
TEC	NULL
which	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
T-cell	NULL
development	NULL
(	NULL
41	NULL
,	NULL
43	NULL
,	NULL
45	NULL
,	NULL
49	NULL
)	NULL
,	NULL
was	NULL
this	NULL
cofactor	NULL
.	NULL

We	NULL
first	NULL
showed	NULL
that	NULL
TEC	NULL
CM	NULL
obtained	NULL
after	NULL
3	NULL
days	NULL
contains	NULL
between	NULL
5	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
IL-7/ml	NULL
per	NULL
10°	NULL
cells	NULL
.	NULL

We	NULL
then	NULL
demonstrated	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
that	NULL
the	NULL
costimulatory	NULL
effect	NULL
of	NULL
the	NULL
TEC	NULL
CM	NULL
was	NULL
abrogated	NULL
when	NULL
this	NULL
medium	NULL
was	NULL
depleted	NULL
of	NULL
IL-7	NULL
by	NULL
using	NULL
an	NULL
antibody	NULL
against	NULL
IL-7	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
TEC	NULL
failed	NULL
to	NULL
sustain	NULL
this	NULL
activity	NULL
when	NULL
thymocytes	NULL
were	NULL
preincubated	NULL
with	NULL
an	NULL
antibody	NULL
against	NULL
the	NULL
specific	NULL
«	NULL
chain	NULL
of	NULL
the	NULL
IL-7	NULL
receptor	NULL
before	NULL
coculture	NULL
.	NULL

The	NULL
role	NULL
of	NULL
IL-7	NULL
was	NULL
also	NULL
confirmed	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
IL-7	NULL
elicited	NULL
a	NULL
strong	NULL
costimulatory	NULL
effect	NULL
with	NULL
TNF	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
with	NULL
IL-1	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
whereas	NULL
IL-6	NULL
and	NULL
GM-CSF	NULL
,	NULL
which	NULL
are	NULL
secreted	NULL
by	NULL
TEC	NULL
(	NULL
34	NULL
)	NULL
and	NULL
involved	NULL
in	NULL
HIV	NULL
replication	NULL
,	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
induced	NULL
by	NULL
IL-1	NULL
or	NULL
TNF	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

activation	NULL
was	NULL
also	NULL
observed	NULL
when	NULL
thymocytes	NULL
were	NULL
treated	NULL
with	NULL
IL-7	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lane	NULL
5	NULL
,	NULL
and	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
antibodies	NULL
against	NULL
TNF	NULL
and	NULL
IL-1	NULL
,	NULL
added	NULL
simultaneously	NULL
with	NULL
IL-7	NULL
at	NULL
the	NULL
start	NULL
of	NULL
the	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
prevented	NULL
this	NULL
induction	NULL
,	NULL
again	NULL
indicating	NULL
that	NULL
IL-7	NULL
plays	NULL
the	NULL
role	NULL
of	NULL
a	NULL
cofactor	NULL
which	NULL
amplifies	NULL
the	NULL
effect	NULL
of	NULL
low	NULL
levels	NULL
of	NULL
TNF	NULL
(	NULL
and	NULL
IL-1	NULL
)	NULL
secreted	NULL
by	NULL
thymocytes	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
argue	NULL
for	NULL
a	NULL
major	NULL
role	NULL
of	NULL
TNF	NULL
in	NULL
maintaining	NULL
NF-kB	NULL
activation	NULL
in	NULL
thymocytes	NULL
,	NULL
but	NULL
this	NULL
activation	NULL
requires	NULL
IL-7	NULL
,	NULL
which	NULL
is	NULL
secreted	NULL
mainly	NULL
by	NULL
TEC	NULL
.	NULL

We	NULL
then	NULL
determined	NULL
whether	NULL
HIV	NULL
LTR	NULL
transactivation	NULL
in	NULL
thymocytes	NULL
was	NULL
also	NULL
dependent	NULL
upon	NULL
the	NULL
stimulation	NULL
by	NULL
these	NULL
cytokines	NULL
.	NULL

To	NULL
emphasize	NULL
the	NULL
transactivation	NULL
,	NULL
we	NULL
used	NULL
a	NULL
combination	NULL
of	NULL
IL-1	NULL
and	NULL
TNF	NULL
(	NULL
termed	NULL
IL-1-TNF	NULL
)	NULL
,	NULL
since	NULL
their	NULL
pathways	NULL
of	NULL
NF-kB	NULL
activation	NULL
are	NULL
known	NULL
to	NULL
be	NULL
synergistic	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Other	NULL
combinations	NULL
of	NULL
cytokines	NULL
were	NULL
also	NULL
used	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Thymocytes	NULL
were	NULL
maintained	NULL
in	NULL
culture	NULL
either	NULL
unstimulated	NULL
or	NULL
treated	NULL
with	NULL
the	NULL
various	NULL
cytokines	NULL
for	NULL
48	NULL
h	NULL
prior	NULL
to	NULL
transfection	NULL
.	NULL

Cotransfection	NULL
was	NULL
then	NULL
performed	NULL
with	NULL
CMV	NULL
EF1-Bgal	NULL
,	NULL
and	NULL
either	NULL
LTR-luc	NULL
or	NULL
LTRAxB-lue	NULL
.	NULL

The	NULL
transfected	NULL
thymocytes	NULL
were	NULL
then	NULL
returned	NULL
for	NULL
an	NULL
additional	NULL
20	NULL
h	NULL
to	NULL
the	NULL
previous	NULL
conditioned	NULL
medium	NULL
prior	NULL
to	NULL
the	NULL
determination	NULL
of	NULL
reporter	NULL
gene	NULL
activities	NULL
.	NULL

The	NULL
activities	NULL
of	NULL
the	NULL
two	NULL
LTRs	NULL
,	NULL
wild	NULL
type	NULL
and	NULL
AB	NULL
,	NULL
were	NULL
of	NULL
the	NULL
same	NULL
level	NULL
in	NULL
nonactivated	NULL
Jurkat	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
whereas	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
wild-type	NULL
LTR	NULL
was	NULL
3.5-fold	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
LTRAxB	NULL
in	NULL
thymocytes	NULL
voL	NULL
.	NULL

73	NULL
,	NULL
1999	NULL
“	NULL
2m	NULL
Thymocytes	NULL
cultured	NULL
for	NULL
45	NULL
hours	NULL
Coculture	NULL
with	NULL
TEC	NULL
-o	NULL
=	NULL
-	NULL
+o	NULL
o	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Contact	NULL
-o	NULL
-	NULL
-	NULL
40k	NULL
e	NULL
k	NULL
e	NULL
-	NULL
+0	NULL
+	NULL
&	NULL
&	NULL
g.	NULL
4	NULL
«	NULL
<	NULL
é	NULL
£	NULL
é	NULL
-	NULL
58	NULL
m	NULL
2	NULL
{	NULL
Po	NULL
OH	NULL
E	NULL
:	NULL
fcik	NULL
f	NULL
£	NULL
$	NULL
8	NULL
os	NULL
(	NULL
3	NULL
‘	NULL
s	NULL
.	NULL

soc	NULL
g	NULL
8	NULL
8	NULL
4	NULL
<	NULL
3§	NULL
Cl	NULL
r-	NULL
affudl	NULL
--	NULL
-=	NULL
-	NULL
>	NULL
<	NULL
p	NULL
n.s	NULL
1	NULL
H	NULL
P3	NULL
n.s	NULL
2	NULL
je	NULL
>	NULL
|	NULL
mal	NULL
[	NULL
as	NULL
wa	NULL
»	NULL
w*	NULL
-	NULL
m	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

TNF	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
IL-1	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
permanently	NULL
induced	NULL
NF-kB	NULL
activity	NULL
present	NULL
in	NULL
thymocytes	NULL
during	NULL
the	NULL
coculture	NULL
with	NULL
TEC	NULL
.	NULL

Thymocytes	NULL
were	NULL
freshly	NULL
isolated	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
cultured	NULL
for	NULL
45	NULL
h	NULL
(	NULL
lanes	NULL
3	NULL
to	NULL
11	NULL
)	NULL
either	NULL
alone	NULL
(	NULL
lane	NULL
3	NULL
[	NULL
Control	NULL
thymocytes	NULL
]	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TEC	NULL
under	NULL
conditions	NULL
avoiding	NULL
contact	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
9	NULL
)	NULL
or	NULL
allowing	NULL
contact	NULL
(	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

During	NULL
the	NULL
coculture	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
(	NULL
lane	NULL
4	NULL
[	NULL
Control	NULL
coculture	NULL
,	NULL
45	NULL
hours	NULL
]	NULL
and	NULL
lane	NULL
10	NULL
[	NULL
Control	NULL
coculture	NULL
]	NULL
)	NULL
or	NULL
were	NULL
treated	NULL
at	NULL
the	NULL
start	NULL
of	NULL
the	NULL
coculture	NULL
with	NULL
antibodies	NULL
respectively	NULL
raised	NULL
against	NULL
TNF	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
IL-6	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
IL-1B	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
with	NULL
the	NULL
antagonist	NULL
of	NULL
the	NULL
IL-1	NULL
receptor	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
or	NULL
with	NULL
eTNF	NULL
plus	NULL
IL-1	NULL
ra	NULL
plus	NULL
IL-6	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
11	NULL
)	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
from	NULL
these	NULL
various	NULL
samples	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
*°P-labeled	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
HIV	NULL
LTR-derived	NULL
«	NULL
B	NULL
motif	NULL
.	NULL

Competition	NULL
(	NULL
comp	NULL
[	NULL
lane	NULL
1	NULL
]	NULL
)	NULL
with	NULL
a	NULL
40-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
was	NULL
used	NULL
to	NULL
confirm	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
DNA-binding	NULL
activity	NULL
detected	NULL
.	NULL

NF-B	NULL
activity	NULL
is	NULL
indicated	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
two	NULL
nonspecific	NULL
(	NULL
n.s	NULL
1	NULL
and	NULL
n.s	NULL
2	NULL
)	NULL
binding	NULL
activities	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
two	NULL
nonspecific	NULL
(	NULL
n.s	NULL
1	NULL
and	NULL
n.s	NULL
2	NULL
)	NULL
binding	NULL
activities	NULL
are	NULL
indicated	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
each	NULL
carried	NULL
out	NULL
on	NULL
a	NULL
different	NULL
thymus	NULL
.	NULL

(	NULL
considered	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
LTR	NULL
,	NULL
independent	NULL
of	NULL
NF-kB	NULL
activation	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

These	NULL
data	NULL
confirmed	NULL
that	NULL
thymocytes	NULL
left	NULL
unstimulated	NULL
even	NULL
for	NULL
48	NULL
h	NULL
were	NULL
not	NULL
completely	NULL
devoid	NULL
of	NULL
NF-kB	NULL
activity	NULL
(	NULL
see	NULL
also	NULL
the	NULL
LTR	NULL
and	NULL
NF-kB	NULL
activity	NULL
[	NULL
Fig	NULL
.	NULL

3	NULL
]	NULL
)	NULL
.	NULL

IL-1-TNF	NULL
stimulation	NULL
further	NULL
enhanced	NULL
this	NULL
level	NULL
(	NULL
ninefold	NULL
)	NULL
.	NULL

The	NULL
transactivation	NULL
level	NULL
observed	NULL
with	NULL
IL-1-TNF	NULL
was	NULL
not	NULL
further	NULL
modified	NULL
by	NULL
addition	NULL
of	NULL
IL-6	NULL
and	NULL
GM-CSF	NULL
.	NULL

Only	NULL
addition	NULL
of	NULL
IL-7	NULL
to	NULL
IL-1-TNF	NULL
led	NULL
to	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
LTR	NULL
transactivation	NULL
(	NULL
30-fold	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
IL-7	NULL
alone	NULL
also	NULL
increased	NULL
HIV-1	NULL
LTR	NULL
activity	NULL
(	NULL
24-fold	NULL
)	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
significant	NULL
NF-kB	NULL
activity	NULL
elicited	NULL
by	NULL
IL-7	NULL
acting	NULL
as	NULL
a	NULL
cofactor	NULL
of	NULL
low	NULL
levels	NULL
of	NULL
TNF	NULL
(	NULL
and	NULL
IL-1	NULL
)	NULL
constitutively	NULL
produced	NULL
by	NULL
thymocytes	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lanes	NULL
5	NULL
through	NULL
7	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
TNF-IL-1	NULL
required	NULL
xB	NULL
sites	NULL
,	NULL
since	NULL
the	NULL
LTRAxB	NULL
was	NULL
unresponsive	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IL-7	NULL
triggered	NULL
LTRAxB	NULL
transactivation	NULL
,	NULL
although	NULL
less	NULL
efficiently	NULL
than	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
LTR	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
cytokine	NULL
acts	NULL
through	NULL
both	NULL
NF-kB-dependent	NULL
and	NULL
NF-	NULL
«	NULL
B-independent	NULL
pathways	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

7B	NULL
we	NULL
show	NULL
that	NULL
the	NULL
transactivation	NULL
induced	NULL
by	NULL
IL-7	NULL
correlates	NULL
with	NULL
the	NULL
weak	NULL
induction	NULL
of	NULL
transcriptional	NULL
activity	NULL
of	NULL
LTRAxB	NULL
in	NULL
thymocytes	NULL
during	NULL
their	NULL
interaction	NULL
with	NULL
TEC	NULL
and	NULL
suggests	NULL
that	NULL
secretion	NULL
of	NULL
IL-7	NULL
by	NULL
TEC	NULL
is	NULL
mainly	NULL
responsible	NULL
for	NULL
this	NULL
effect	NULL
.	NULL

However	NULL
,	NULL
the	NULL
induc-	NULL
NF-	NULL
«	NULL
B-DEPENDENT	NULL
HIV-1	NULL
REPLICATION	NULL
IN	NULL
THYMUS	NULL
-	NULL
2069	NULL
tion	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
wild-type	NULL
LTR	NULL
by	NULL
TEC	NULL
is	NULL
much	NULL
more	NULL
efficient	NULL
than	NULL
that	NULL
of	NULL
the	NULL
LTRAxB	NULL
.	NULL

DISCUSSION	NULL
We	NULL
report	NULL
here	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
a	NULL
major	NULL
prerequisite	NULL
for	NULL
a	NULL
high	NULL
level	NULL
of	NULL
HIV-1	NULL
replication	NULL
in	NULL
thymocytes	NULL
and	NULL
that	NULL
the	NULL
interaction	NULL
of	NULL
infected	NULL
thymocytes	NULL
with	NULL
TEC	NULL
is	NULL
necessary	NULL
for	NULL
such	NULL
an	NULL
induction	NULL
.	NULL

This	NULL
conclusion	NULL
was	NULL
drawn	NULL
from	NULL
the	NULL
fact	NULL
that	NULL
an	NULL
HIV-1	NULL
provirus	NULL
with	NULL
its	NULL
kB	NULL
sites	NULL
deleted	NULL
failed	NULL
to	NULL
replicate	NULL
in	NULL
thymocytes	NULL
whereas	NULL
the	NULL
wild-type	NULL
provirus	NULL
exhibited	NULL
a	NULL
high	NULL
level	NULL
of	NULL
replication	NULL
,	NULL
although	NULL
only	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TEC	NULL
.	NULL

The	NULL
active	NULL
HIV	NULL
replication	NULL
observed	NULL
within	NULL
the	NULL
thymus	NULL
(	NULL
58-60	NULL
)	NULL
thus	NULL
suggested	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
permanently	NULL
induced	NULL
in	NULL
the	NULL
thymic	NULL
microenvironment	NULL
.	NULL

We	NULL
confirmed	NULL
that	NULL
a	NULL
high	NULL
level	NULL
of	NULL
NF-kB	NULL
binding	NULL
activity	NULL
was	NULL
present	NULL
within	NULL
this	NULL
organ	NULL
,	NULL
taken	NULL
as	NULL
a	NULL
whole	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
detection	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
kB	NULL
complexes	NULL
in	NULL
vivo	NULL
in	NULL
human	NULL
thymus	NULL
by	NULL
in	NULL
situ	NULL
immunostaining	NULL
(	NULL
11	NULL
)	NULL
.	NULL

We	NULL
also	NULL
detected	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
distinct	NULL
NF-kB	NULL
complexes	NULL
.	NULL

p50-p65	NULL
was	NULL
the	NULL
prevalent	NULL
complex	NULL
,	NULL
but	NULL
p50-p50	NULL
and	NULL
p50-RelIB	NULL
were	NULL
also	NULL
present	NULL
.	NULL

p52-containing	NULL
complexes	NULL
,	NULL
although	NULL
minor	NULL
,	NULL
were	NULL
also	NULL
detected	NULL
.	NULL

The	NULL
difference	NULL
between	NULL
whole	NULL
thymus	NULL
and	NULL
thymocytes	NULL
suggests	NULL
that	NULL
the	NULL
major	NULL
RelB	NULL
complexes	NULL
detected	NULL
in	NULL
whole	NULL
thymus	NULL
were	NULL
mainly	NULL
derived	NULL
from	NULL
TEC	NULL
,	NULL
confirming	NULL
previous	NULL
reports	NULL
of	NULL
results	NULL
obtained	NULL
with	NULL
murine	NULL
thymus	NULL
(	NULL
7	NULL
,	NULL
37	NULL
,	NULL
62	NULL
)	NULL
.	NULL

We	NULL
then	NULL
showed	NULL
that	NULL
NF-kB	NULL
activity	NULL
observed	NULL
in	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
was	NULL
the	NULL
result	NULL
of	NULL
specific	NULL
signals	NULL
delivered	NULL
within	NULL
the	NULL
microenvironment	NULL
.	NULL

This	NULL
activity	NULL
,	NULL
which	NULL
is	NULL
mainly	NULL
due	NULL
to	NULL
p50-p65	NULL
complexes	NULL
,	NULL
decreased	NULL
when	NULL
thymocytes	NULL
were	NULL
cultured	NULL
alone	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
at	NULL
least	NULL
part	NULL
of	NULL
the	NULL
activation	NULL
signals	NULL
comes	NULL
from	NULL
the	NULL
interaction	NULL
with	NULL
TEC	NULL
,	NULL
since	NULL
addition	NULL
of	NULL
TEC	NULL
to	NULL
thymocyte	NULL
culture	NULL
prevented	NULL
this	NULL
progressive	NULL
loss	NULL
of	NULL
activation	NULL
.	NULL

The	NULL
same	NULL
effect	NULL
was	NULL
observed	NULL
with	NULL
autologous	NULL
and	NULL
heterologous	NULL
TEC	NULL
,	NULL
excluding	NULL
the	NULL
potential	NULL
involvement	NULL
of	NULL
a	NULL
mixed	NULL
lymphocyte	NULL
reaction	NULL
.	NULL

However	NULL
,	NULL
compared	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
,	NULL
the	NULL
maintenance	NULL
of	NULL
NF-kB	NULL
activity	NULL
during	NULL
coculture	NULL
with	NULL
TEC	NULL
was	NULL
less	NULL
efficient	NULL
,	NULL
but	NULL
the	NULL
nature	NULL
and	NULL
ratio	NULL
of	NULL
the	NULL
complexes	NULL
were	NULL
similar	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
could	NULL
not	NULL
exclude	NULL
the	NULL
possible	NULL
role	NULL
of	NULL
other	NULL
cells	NULL
or	NULL
factors	NULL
within	NULL
the	NULL
microenvironment	NULL
in	NULL
strengthening	NULL
NF-kB	NULL
activity	NULL
.	NULL

We	NULL
can	NULL
also	NULL
argue	NULL
that	NULL
disruption	NULL
of	NULL
thymocyte-TEC	NULL
interaction	NULL
during	NULL
thymus	NULL
preparation	NULL
might	NULL
not	NULL
be	NULL
immediately	NULL
and	NULL
efficiently	NULL
restored	NULL
by	NULL
mixing	NULL
these	NULL
two	NULL
cell	NULL
subpopulations	NULL
in	NULL
the	NULL
same	NULL
culture	NULL
dish	NULL
,	NULL
particularly	NULL
with	NULL
regard	NULL
to	NULL
the	NULL
necessary	NULL
accumulation	NULL
of	NULL
soluble	NULL
factors	NULL
.	NULL

The	NULL
high	NULL
level	NULL
of	NULL
active	NULL
NF-	NULL
«	NULL
xB	NULL
complexes	NULL
,	NULL
including	NULL
p50-p65	NULL
,	NULL
in	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
as	NULL
well	NULL
as	NULL
in	NULL
thymocytes	NULL
cocultured	NULL
with	NULL
TEC	NULL
was	NULL
postulated	NULL
to	NULL
correlate	NULL
with	NULL
a	NULL
strong	NULL
activation	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
.	NULL

By	NULL
using	NULL
transfection	NULL
assays	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
the	NULL
decrease	NULL
of	NULL
NF-kB	NULL
activity	NULL
in	NULL
thymocytes	NULL
in	NULL
culture	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
decrease	NULL
of	NULL
LTR	NULL
activity	NULL
,	NULL
except	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TEC	NULL
,	NULL
which	NULL
maintained	NULL
a	NULL
high	NULL
level	NULL
of	NULL
both	NULL
NF-kB	NULL
and	NULL
LTR	NULL
activity	NULL
.	NULL

We	NULL
also	NULL
confirmed	NULL
that	NULL
this	NULL
high	NULL
activity	NULL
of	NULL
the	NULL
LTR	NULL
was	NULL
dependent	NULL
upon	NULL
kB	NULL
binding	NULL
sites	NULL
since	NULL
it	NULL
was	NULL
strongly	NULL
decreased	NULL
by	NULL
deletion	NULL
of	NULL
these	NULL
sites	NULL
(	NULL
LTRAxB-luc	NULL
)	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
the	NULL
xB	NULL
responsive	NULL
element	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
comparing	NULL
the	NULL
luciferase	NULL
activity	NULL
obtained	NULL
with	NULL
the	NULL
3Enh-TK-luc	NULL
construct	NULL
with	NULL
that	NULL
obtained	NULL
with	NULL
the	NULL
control	NULL
vector	NULL
TK-luc	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
activity	NULL
indicated	NULL
as	NULL
n.s	NULL
1	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
observed	NULL
in	NULL
EMSA	NULL
,	NULL
was	NULL
not	NULL
significantly	NULL
modified	NULL
by	NULL
competition	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
probe	NULL
.	NULL

In	NULL
consequence	NULL
,	NULL
this	NULL
activity	NULL
was	NULL
indicated	NULL
as	NULL
nonspecific	NULL
.	NULL

However	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
modulated	NULL
by	NULL
certain	NULL
cytokines	NULL
of	NULL
2070	NULL
CHENE	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
VirRou	NULL
.	NULL

A	NULL
Freshly	NULL
isolated	NULL
_	NULL
Thymocytes	NULL
Thymocytes	NULL
B	NULL
thymocytes	NULL
_	NULL
cultured	NULL
30	NULL
hours	NULL
cultured	NULL
60	NULL
hours	NULL
Thymocytes	NULL
Thymocytes	NULL
cultured	NULL
45	NULL
hours	NULL
cocultured	NULL
45	NULL
hours	NULL
with	NULL
TEC	NULL
-a	NULL
z	NULL
z	NULL
2	NULL
E	NULL
C	NULL
C	NULL
&	NULL
f	NULL
$	NULL
s	NULL
to	NULL
fs	NULL
%	NULL
got	NULL
fois	NULL
©	NULL
-	NULL
=	NULL
E	NULL
5	NULL
5	NULL
Eo	NULL
80	NULL
0	NULL
$	NULL
bs	NULL
§§	NULL
p	NULL
3	NULL
8	NULL
s	NULL
``	NULL
3	NULL
f	NULL
bo	NULL
:	NULL
g	NULL
g	NULL
3	NULL
?	NULL

5	NULL
q	NULL
2	NULL
B	NULL
f	NULL
gf	NULL
-is	NULL
8	NULL
«	NULL
im=NF-	NULL
<	NULL
B	NULL
.	NULL

.	NULL

«	NULL
m=	NULL
¥	NULL
_|	NULL
«	NULL
«	NULL
f=n.s	NULL
1	NULL
1	NULL
20	NULL
3	NULL
4	NULL
5	NULL
60	NULL
7	NULL
8s	NULL
9	NULL
1	NULL
20	NULL
3	NULL
40	NULL
5	NULL
600	NULL
7	NULL
8	NULL
Thymocytes	NULL
Thymocytes	NULL
C	NULL
cultured	NULL
45	NULL
hours	NULL
D	NULL
cultured	NULL
45	NULL
hours	NULL
8	NULL
P	NULL
ﬁg	NULL
&	NULL
a	NULL
E	NULL
c	NULL
2	NULL
+	NULL
2	NULL
£	NULL
B	NULL
a	NULL
£	NULL
&	NULL
a	NULL
.	NULL

7	NULL
6	NULL
ro	NULL
+	NULL
a	NULL
+T	NULL
8	NULL
&	NULL
m	NULL
ag	NULL
o	NULL
t	NULL
tot	NULL
50	NULL
t	NULL
11:3	NULL
8	NULL
#	NULL
8	NULL
B1	NULL
.	NULL

0	NULL
#	NULL
#	NULL
@	NULL
8°	NULL
#	NULL
#	NULL
+	NULL
.	NULL

NF-xB	NULL
g	NULL
]	NULL
fl	NULL
ns	NULL
1	NULL
«	NULL
=n	NULL
.	NULL

1	NULL
1	NULL
20	NULL
3	NULL
4	NULL
5°	NULL
60	NULL
7	NULL
1	NULL
2	NULL
3	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

TNF	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
IL-1	NULL
induce	NULL
NF-B	NULL
activity	NULL
in	NULL
thymocytes	NULL
,	NULL
and	NULL
IL-7	NULL
is	NULL
required	NULL
for	NULL
this	NULL
effect	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
(	NULL
panel	NULL
A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
from	NULL
thymocytes	NULL
cultivated	NULL
for	NULL
30	NULL
,	NULL
60	NULL
,	NULL
or	NULL
45	NULL
h.	NULL
(	NULL
A	NULL
)	NULL
During	NULL
the	NULL
indicated	NULL
culture	NULL
times	NULL
,	NULL
thymocytes	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
(	NULL
lane	NULL
1	NULL
,	NULL
control	NULL
for	NULL
freshly	NULL
isolated	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
control	NULL
30	NULL
h	NULL
;	NULL
and	NULL
lane	NULL
5	NULL
,	NULL
control	NULL
60	NULL
h	NULL
)	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
TNF	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
,	NULL
IL-1B	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
7	NULL
)	NULL
,	NULL
or	NULL
TNF	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TEC	NULL
CM	NULL
(	NULL
TEC	NULL
CM	NULL
+	NULL
TNF	NULL
)	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

TEC	NULL
conditioned	NULL
medium	NULL
was	NULL
also	NULL
added	NULL
alone	NULL
(	NULL
lane	NULL
8	NULL
[	NULL
TEC	NULL
CMJ	NULL
)	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
here	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
carried	NULL
out	NULL
on	NULL
three	NULL
thymuses	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Thymocytes	NULL
were	NULL
cultured	NULL
for	NULL
45	NULL
h	NULL
either	NULL
untreated	NULL
(	NULL
lane	NULL
1	NULL
,	NULL
control	NULL
45	NULL
h	NULL
)	NULL
,	NULL
with	NULL
TNF	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
with	NULL
TEC	NULL
CM	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
with	NULL
TNF	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TEC	NULL
CM	NULL
(	NULL
TEC	NULL
CM	NULL
+	NULL
TNF	NULL
)	NULL
preincubated	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
or	NULL
not	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
with	NULL
antibody	NULL
against	NULL
IL-7	NULL
.	NULL

In	NULL
lanes	NULL
6	NULL
to	NULL
8	NULL
,	NULL
the	NULL
thymocytes	NULL
were	NULL
left	NULL
untreated	NULL
for	NULL
6	NULL
h	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
incubated	NULL
with	NULL
an	NULL
antibody	NULL
against	NULL
IL-7Ra	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
with	NULL
an	NULL
IgG1	NULL
control	NULL
serum	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
before	NULL
being	NULL
cocultured	NULL
with	NULL
TEC	NULL
for	NULL
45	NULL
h.	NULL
The	NULL
data	NULL
shown	NULL
here	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
carried	NULL
out	NULL
on	NULL
two	NULL
thymuses	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Cells	NULL
were	NULL
left	NULL
untreated	NULL
for	NULL
the	NULL
45	NULL
h	NULL
of	NULL
the	NULL
culture	NULL
(	NULL
lane	NULL
1	NULL
,	NULL
control	NULL
45	NULL
h	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
IL-1B	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
TNF	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
IL-1B	NULL
plus	NULL
TNF	NULL
plus	NULL
IL-6	NULL
plus	NULL
GM-CSF	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
IL-7	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
IL-7	NULL
plus	NULL
IL-18	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
or	NULL
IL-7	NULL
plus	NULL
TNF	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
carried	NULL
out	NULL
on	NULL
three	NULL
thymuses	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Thymocytes	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
lane	NULL
1	NULL
,	NULL
control	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
IL-7	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
IL-7	NULL
in	NULL
presence	NULL
of	NULL
anti-TNF	NULL
and	NULL
II-1ra	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
P-labeled	NULL
oligonucleotide	NULL
representing	NULL
xB	NULL
motif	NULL
.	NULL

NF-kB	NULL
activity	NULL
is	NULL
indicated	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
,	NULL
each	NULL
carried	NULL
out	NULL
on	NULL
a	NULL
different	NULL
thymus	NULL
.	NULL

the	NULL
coculture	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

This	NULL
activity	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
KBF2/	NULL
not	NULL
exclude	NULL
a	NULL
role	NULL
of	NULL
the	NULL
contact	NULL
in	NULL
sustaining	NULL
the	NULL
levels	NULL
of	NULL
RBP	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
kB	NULL
sites	NULL
(	NULL
25	NULL
)	NULL
,	NULL
albeit	NULL
with	NULL
these	NULL
cytokines	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
TNF	NULL
,	NULL
secreted	NULL
mainly	NULL
by	NULL
an	NULL
affinity	NULL
much	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
NF-kB	NULL
(	NULL
252	NULL
)	NULL
.	NULL

thymocytes	NULL
,	NULL
represented	NULL
a	NULL
major	NULL
requirement	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
acti-	NULL
Since	NULL
certain	NULL
nucleotides	NULL
of	NULL
the	NULL
xB	NULL
element	NULL
within	NULL
the	NULL
LTR	NULL
vation	NULL
,	NULL
since	NULL
antibodies	NULL
against	NULL
TNF	NULL
abrogated	NULL
the	NULL
inductive	NULL
were	NULL
found	NULL
to	NULL
participate	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
other	NULL
transcription	NULL
effect	NULL
of	NULL
the	NULL
coculture	NULL
.	NULL

IL-1	NULL
,	NULL
produced	NULL
by	NULL
both	NULL
TEC	NULL
and	NULL
thy-factors	NULL
such	NULL
as	NULL
RBP/KBF2	NULL
(	NULL
25	NULL
)	NULL
,	NULL
NF-AT	NULL
(	NULL
29	NULL
)	NULL
,	NULL
ets	NULL
(	NULL
53	NULL
)	NULL
,	NULL
and	NULL
_	NULL
mocytes	NULL
(	NULL
41	NULL
,	NULL
66	NULL
)	NULL
,	NULL
modestly	NULL
participated	NULL
in	NULL
this	NULL
induction	NULL
.	NULL

Un-GABP	NULL
(	NULL
13	NULL
)	NULL
,	NULL
it	NULL
was	NULL
necessary	NULL
to	NULL
formally	NULL
demonstrate	NULL
that	NULL
LTR	NULL
expectedly	NULL
,	NULL
these	NULL
two	NULL
cytokines	NULL
were	NULL
not	NULL
sufficient	NULL
to	NULL
maintain	NULL
transactivation	NULL
was	NULL
regulated	NULL
by	NULL
members	NULL
of	NULL
the	NULL
Rel/NF-	NULL
«	NULL
B	NULL
a	NULL
long-term	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
culture	NULL
.	NULL

We	NULL
then	NULL
demon-family	NULL
.	NULL

We	NULL
therefore	NULL
cotransfected	NULL
a	NULL
mutated	NULL
IxBa	NULL
molecule	NULL
strated	NULL
that	NULL
IL-7	NULL
,	NULL
secreted	NULL
mainly	NULL
by	NULL
TEC	NULL
(	NULL
42	NULL
,	NULL
49	NULL
)	NULL
,	NULL
induced	NULL
an	NULL
which	NULL
can	NULL
not	NULL
be	NULL
phosphorylated	NULL
and	NULL
degraded	NULL
(	NULL
63	NULL
)	NULL
together	NULL
NF-kB	NULL
activity	NULL
in	NULL
thymocytes	NULL
by	NULL
acting	NULL
as	NULL
a	NULL
cofactor	NULL
of	NULL
low	NULL
with	NULL
an	NULL
HIV	NULL
LTR	NULL
.	NULL

Overexpression	NULL
of	NULL
this	NULL
mutated	NULL
form	NULL
of	NULL
levels	NULL
of	NULL
TNF	NULL
and	NULL
IL-1	NULL
constitutively	NULL
produced	NULL
by	NULL
thymocytes	NULL
IxBa	NULL
,	NULL
acting	NULL
in	NULL
competition	NULL
with	NULL
endogenous	NULL
IxBa	NULL
,	NULL
led	NULL
to	NULL
a	NULL
(	NULL
12	NULL
,	NULL
16	NULL
,	NULL
66	NULL
)	NULL
.	NULL

This	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
IL-7-dose-dependent	NULL
decrease	NULL
in	NULL
LTR	NULL
activity	NULL
.	NULL

The	NULL
highest	NULL
concen-	NULL
induced	NULL
NF-kB	NULL
activity	NULL
could	NULL
be	NULL
abolished	NULL
by	NULL
antibodies	NULL
tration	NULL
of	NULL
IxBa	NULL
«	NULL
-DN	NULL
decreased	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
wild-type	NULL
against	NULL
IL-1	NULL
and	NULL
TNF	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
lead	NULL
to	NULL
the	NULL
con-LTR	NULL
to	NULL
a	NULL
value	NULL
comparable	NULL
to	NULL
that	NULL
obtained	NULL
with	NULL
the	NULL
LTR-	NULL
clusion	NULL
that	NULL
TNF	NULL
is	NULL
the	NULL
major	NULL
inducer	NULL
of	NULL
NF-kB	NULL
activity	NULL
in	NULL
AxB	NULL
.	NULL

These	NULL
data	NULL
confirm	NULL
that	NULL
enhanced	NULL
transactivation	NULL
of	NULL
the	NULL
thymocytes	NULL
and	NULL
that	NULL
IL-1	NULL
has	NULL
a	NULL
modest	NULL
synergistic	NULL
effect	NULL
.	NULL

IL-7	NULL
LTR	NULL
is	NULL
triggered	NULL
by	NULL
the	NULL
ReI/NF-	NULL
«	NULL
B	NULL
family	NULL
and	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
required	NULL
for	NULL
the	NULL
maintenance	NULL
of	NULL
this	NULL
activity	NULL
,	NULL
acting	NULL
as	NULL
an	NULL
activity	NULL
in	NULL
thymocytes	NULL
is	NULL
not	NULL
constitutive	NULL
but	NULL
results	NULL
from	NULL
a	NULL
important	NULL
cofactor	NULL
.	NULL

It	NULL
is	NULL
at	NULL
first	NULL
sight	NULL
surprising	NULL
that	NULL
in	NULL
our	NULL
permanent	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

previous	NULL
study	NULL
(	NULL
48	NULL
)	NULL
,	NULL
thymocytes	NULL
were	NULL
capable	NULL
of	NULL
replicating	NULL
the	NULL
The	NULL
major	NULL
role	NULL
of	NULL
soluble	NULL
factors	NULL
in	NULL
NF-kB	NULL
activation	NULL
was	NULL
virus	NULL
in	NULL
vitro	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-7	NULL
addition	NULL
(	NULL
in	NULL
the	NULL
presence	NULL
first	NULL
demonstrated	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
thymocyte-TEC	NULL
interaction	NULL
of	NULL
TNF	NULL
,	NULL
IL-1	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
IL-6	NULL
)	NULL
.	NULL

The	NULL
possible	NULL
explanation	NULL
is	NULL
was	NULL
efficient	NULL
even	NULL
in	NULL
absence	NULL
of	NULL
cell-to-cell	NULL
contact	NULL
.	NULL

This	NULL
does	NULL
that	NULL
IL-7	NULL
was	NULL
expressed	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
the	NULL
thymocyte	NULL
culture	NULL
.	NULL

voL	NULL
.	NULL

73	NULL
,	NULL
1999	NULL
A	NULL
NF-	NULL
«	NULL
B-DEPENDENT	NULL
HIV-1	NULL
REPLICATION	NULL
IN	NULL
THYMUS	NULL
B	NULL
2071	NULL
+	NULL
+	NULL
+	NULL
-	NULL
Thymocytes	NULL
50	NULL
4	NULL
Coculture	NULL
>	NULL
Bo	NULL
sq	NULL
C	NULL
+	NULL
~	NULL
_+	NULL
wih	NULL
TEC	NULL
«	NULL
m	NULL
>	NULL
é	NULL
40	NULL
-	NULL
33	NULL
31,0	NULL
J	NULL
[	NULL
s	NULL
3	NULL
e	NULL
A	NULL
3	NULL
304	NULL
=	NULL
\	NULL
E	NULL
3	NULL
is-	NULL
§	NULL
jaw	NULL
``	NULL
3	NULL
B-	NULL
G	NULL
104	NULL
E	NULL
.	NULL

\	NULL
5	NULL
3	NULL
9,0	NULL
\	NULL
Z	NULL
104	NULL
5	NULL
»	NULL
§	NULL
\	NULL
\	NULL
\	NULL
es	NULL
o	NULL
.	NULL

By	NULL
7	NULL
,	NULL
|	NULL
$	NULL
s	NULL
SS	NULL
&	NULL
Sy	NULL
30	NULL
R	NULL
i	NULL
.	NULL
}	NULL

E	NULL
€	NULL
0	NULL
RB	NULL
i	NULL
.	NULL

3	NULL
5	NULL
E	NULL
ci-le	NULL
E	NULL
5	NULL
E	NULL
78	NULL
*~	NULL
E	NULL
cotransfected	NULL
_	NULL
LITBRve	NULL
LTRAxB-lue	NULL
e	NULL
E	NULL
€	NULL
3	NULL
6	NULL
f	NULL
$	NULL
$	NULL
3	NULL
plasmids	NULL
:	NULL
_	NULL
CMV	NULL
:	NULL
Tat	NULL
_	NULL
CMV-Tat	NULL
-	NULL
-	NULL
a	NULL
--	NULL
4G	NULL
7	NULL
*	NULL
EF1-Bgal	NULL
EF1-Bgal	NULL
a	NULL
+	NULL
&	NULL
a	NULL
+	NULL
é	NULL
=	NULL
=	NULL
=	NULL
C	NULL
L	NULL
Lp	NULL
d	NULL
|	NULL
LTR-lue	NULL
LTRAxB-lue	NULL
``	NULL
-	NULL
CMV-Tat	NULL
CMV-Tat	NULL
P	NULL
'	NULL
EF1-Bgal	NULL
EFL-Bgal	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

(	NULL
A	NULL
)	NULL
LTR	NULL
transactivation	NULL
in	NULL
thymocytes	NULL
is	NULL
triggered	NULL
by	NULL
TNF	NULL
and	NULL
IL-1	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-7	NULL
.	NULL

Freshly	NULL
isolated	NULL
thymocytes	NULL
were	NULL
precultured	NULL
for	NULL
48	NULL
h	NULL
alone	NULL
or	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
cytokines	NULL
as	NULL
indicated	NULL
prior	NULL
to	NULL
cotransfection	NULL
with	NULL
either	NULL
LTR-lue	NULL
,	NULL
CMV-tat	NULL
,	NULL
and	NULL
EF1-Bgal	NULL
or	NULL
LTRAB-luc	NULL
,	NULL
CMV-tat	NULL
,	NULL
and	NULL
EF1-Bgal	NULL
.	NULL

The	NULL
plasmids	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
at	NULL
the	NULL
respective	NULL
amounts	NULL
of	NULL
10	NULL
,	NULL
2.5	NULL
,	NULL
and	NULL
10	NULL
ug	NULL
per	NULL
10	NULL
``	NULL
cells	NULL
.	NULL

The	NULL
transfected	NULL
thymocytes	NULL
were	NULL
then	NULL
returned	NULL
for	NULL
an	NULL
additional	NULL
20	NULL
h	NULL
under	NULL
the	NULL
previous	NULL
culture	NULL
conditions	NULL
prior	NULL
to	NULL
determination	NULL
of	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
.	NULL

LTR	NULL
activity	NULL
was	NULL
expressed	NULL
as	NULL
normalized	NULL
luciferase	NULL
activity	NULL
.	NULL

Numbers	NULL
at	NULL
the	NULL
top	NULL
of	NULL
the	NULL
columns	NULL
represent	NULL
fold	NULL
amplification	NULL
relative	NULL
to	NULL
luciferase	NULL
expression	NULL
in	NULL
unstimulated	NULL
thymocytes	NULL
transfected	NULL
with	NULL
LTRAxB-luc	NULL
(	NULL
level	NULL
of	NULL
NF-xB-independent	NULL
activity	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
carried	NULL
out	NULL
on	NULL
three	NULL
thymuses	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Interaction	NULL
of	NULL
thymocytes	NULL
with	NULL
TEC	NULL
also	NULL
induces	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
independent	NULL
LTR	NULL
transactivation	NULL
in	NULL
thymocytes	NULL
.	NULL

Freshly	NULL
isolated	NULL
thymocytes	NULL
were	NULL
precultured	NULL
for	NULL
48	NULL
h	NULL
alone	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TEC	NULL
prior	NULL
to	NULL
cotransfection	NULL
with	NULL
either	NULL
LTR-lue	NULL
,	NULL
CMV-tat	NULL
,	NULL
and	NULL
EF1-Bgal	NULL
or	NULL
LTRAxB-luc	NULL
,	NULL
CMV-tat	NULL
,	NULL
and	NULL
EF1-Bgal	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
panel	NULL
A	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
,	NULL
cach	NULL
carried	NULL
out	NULL
on	NULL
a	NULL
different	NULL
thymus	NULL
.	NULL

IL-7	NULL
might	NULL
be	NULL
provided	NULL
either	NULL
by	NULL
the	NULL
thymocytes	NULL
themselves	NULL
,	NULL
which	NULL
express	NULL
at	NULL
least	NULL
detectable	NULL
IL-7	NULL
mRNA	NULL
(	NULL
41	NULL
,	NULL
66	NULL
)	NULL
,	NULL
or	NULL
by	NULL
stromal	NULL
cells	NULL
(	NULL
42	NULL
,	NULL
49	NULL
)	NULL
,	NULL
which	NULL
might	NULL
remain	NULL
at	NULL
a	NULL
low	NULL
level	NULL
in	NULL
the	NULL
thymocyte	NULL
preparation	NULL
,	NULL
although	NULL
the	NULL
purity	NULL
of	NULL
the	NULL
thymocyte	NULL
population	NULL
was	NULL
estimated	NULL
to	NULL
be	NULL
99	NULL
%	NULL
.	NULL

This	NULL
low	NULL
level	NULL
of	NULL
IL-7	NULL
might	NULL
then	NULL
be	NULL
sufficient	NULL
to	NULL
permit	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
saturating	NULL
concentrations	NULL
of	NULL
TNF	NULL
and	NULL
IL-1	NULL
added	NULL
to	NULL
the	NULL
thymocyte	NULL
culture	NULL
medium	NULL
.	NULL

This	NULL
hypothesis	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
HIV-1	NULL
replication	NULL
in	NULL
thymocytes	NULL
cultured	NULL
with	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
TNF	NULL
,	NULL
and	NULL
GM-CSF	NULL
or	NULL
cocultured	NULL
with	NULL
TEC	NULL
was	NULL
delayed	NULL
when	NULL
an	NULL
anti-human	NULL
IL-7	NULL
antiserum	NULL
was	NULL
added	NULL
at	NULL
the	NULL
start	NULL
of	NULL
the	NULL
culture	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
level	NULL
of	NULL
replication	NULL
obtained	NULL
in	NULL
thymocytes	NULL
in	NULL
vitro	NULL
when	NULL
IL-7	NULL
was	NULL
used	NULL
with	NULL
TNF	NULL
,	NULL
IL-1	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
IL-6	NULL
was	NULL
much	NULL
higher	NULL
than	NULL
in	NULL
absence	NULL
of	NULL
IL-7	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
transfection	NULL
experiments	NULL
performed	NULL
on	NULL
thymocytes	NULL
after	NULL
48	NULL
h	NULL
in	NULL
culture	NULL
,	NULL
showing	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
IL-7	NULL
to	NULL
IL-1-TNF	NULL
led	NULL
to	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
LTR	NULL
transactivation	NULL
.	NULL

Several	NULL
hypotheses	NULL
might	NULL
be	NULL
proposed	NULL
to	NULL
explain	NULL
the	NULL
role	NULL
of	NULL
IL-7	NULL
in	NULL
the	NULL
NF-kB-dependent	NULL
pathway	NULL
.	NULL

IL-7	NULL
increases	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
AP1	NULL
transcription	NULL
factor	NULL
(	NULL
17	NULL
)	NULL
,	NULL
which	NULL
is	NULL
able	NULL
to	NULL
physically	NULL
interact	NULL
and	NULL
synergize	NULL
with	NULL
NF-kB	NULL
(	NULL
55	NULL
)	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
AP1	NULL
activity	NULL
could	NULL
also	NULL
directly	NULL
upregu-late	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
p75	NULL
,	NULL
since	NULL
an	NULL
API1-responsive	NULL
element	NULL
is	NULL
present	NULL
in	NULL
the	NULL
5	NULL
'	NULL
regulatory	NULL
region	NULL
of	NULL
its	NULL
gene	NULL
(	NULL
51	NULL
)	NULL
.	NULL

This	NULL
last	NULL
hypothesis	NULL
is	NULL
difficult	NULL
to	NULL
demonstrate	NULL
by	NULL
using	NULL
the	NULL
total	NULL
freshly	NULL
isolated	NULL
thymocyte	NULL
population	NULL
,	NULL
in	NULL
which	NULL
the	NULL
number	NULL
of	NULL
thymocytes	NULL
expressing	NULL
this	NULL
receptor	NULL
never	NULL
exceeded	NULL
3	NULL
%	NULL
by	NULL
cytofluorometric	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
IL-7	NULL
receptor	NULL
is	NULL
restricted	NULL
to	NULL
certain	NULL
subsets	NULL
of	NULL
thymocytes	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Work	NULL
to	NULL
identify	NULL
the	NULL
subpopulations	NULL
of	NULL
thymocytes	NULL
responsible	NULL
for	NULL
the	NULL
high	NULL
level	NULL
of	NULL
HIV	NULL
replication	NULL
is	NULL
in	NULL
progress	NULL
in	NULL
our	NULL
laboratory	NULL
.	NULL

Use	NULL
of	NULL
these	NULL
subpopulations	NULL
,	NULL
which	NULL
might	NULL
be	NULL
characterized	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
both	NULL
IL-7	NULL
and	NULL
TNF	NULL
receptors	NULL
(	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
IL-1	NULL
receptor	NULL
)	NULL
,	NULL
will	NULL
allow	NULL
us	NULL
to	NULL
determine	NULL
whether	NULL
IL-7	NULL
modulates	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
TNF	NULL
p75	NULL
receptor	NULL
.	NULL

Interestingly	NULL
,	NULL
IL-7	NULL
also	NULL
increases	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
LTRAkB	NULL
construct	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
cytokine	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
an	NULL
NF-	NULL
«	NULL
B-independent	NULL
pathway	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
AP1	NULL
,	NULL
IL-7	NULL
activates	NULL
several	NULL
other	NULL
transcription	NULL
factors	NULL
including	NULL
NF-AT	NULL
(	NULL
17	NULL
)	NULL
,	NULL
Stat	NULL
3	NULL
,	NULL
and	NULL
Stat	NULL
5	NULL
(	NULL
36	NULL
,	NULL
38	NULL
)	NULL
.	NULL

By	NULL
systematic	NULL
mutagenesis	NULL
within	NULL
the	NULL
LTR	NULL
,	NULL
we	NULL
are	NULL
in	NULL
the	NULL
process	NULL
of	NULL
identifying	NULL
the	NULL
sequence	NULL
responsible	NULL
for	NULL
this	NULL
effect	NULL
.	NULL

The	NULL
magnitude	NULL
of	NULL
transactivation	NULL
through	NULL
this	NULL
pathway	NULL
is	NULL
much	NULL
lower	NULL
than	NULL
that	NULL
observed	NULL
through	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
one	NULL
.	NULL

This	NULL
is	NULL
very	NULL
possibly	NULL
the	NULL
reason	NULL
why	NULL
no	NULL
virus	NULL
replication	NULL
was	NULL
detectable	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
xB	NULL
sites	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
NF-xB	NULL
activity	NULL
is	NULL
not	NULL
strictly	NULL
necessary	NULL
to	NULL
induce	NULL
LTR	NULL
transactivation	NULL
but	NULL
is	NULL
necessary	NULL
to	NULL
attain	NULL
a	NULL
high	NULL
level	NULL
of	NULL
HIV	NULL
replication	NULL
.	NULL

Similar	NULL
conclusions	NULL
have	NULL
been	NULL
2072	NULL
CHENE	NULL
ET	NULL
AL	NULL
.	NULL

reached	NULL
concerning	NULL
the	NULL
involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
HIV	NULL
replication	NULL
in	NULL
T	NULL
lymphocytes	NULL
(	NULL
8	NULL
)	NULL
.	NULL

It	NULL
is	NULL
worth	NULL
noting	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transactivation	NULL
of	NULL
the	NULL
LTR	NULL
is	NULL
highly	NULL
dependent	NULL
on	NULL
the	NULL
NF-kB	NULL
complexes	NULL
present	NULL
in	NULL
a	NULL
given	NULL
cell	NULL
and	NULL
in	NULL
its	NULL
microenvironment	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
in	NULL
peripheral	NULL
resting	NULL
T	NULL
lymphocytes	NULL
,	NULL
an	NULL
inactive	NULL
p50	NULL
homodimer	NULL
constitutively	NULL
occupies	NULL
the	NULL
kB	NULL
sites	NULL
,	NULL
preventing	NULL
LTR	NULL
activation	NULL
by	NULL
p50-p65	NULL
induced	NULL
by	NULL
TNF	NULL
or	NULL
IL-1	NULL
.	NULL

The	NULL
major	NULL
stimulus	NULL
responsible	NULL
for	NULL
an	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transactivation	NULL
is	NULL
the	NULL
recognition	NULL
of	NULL
a	NULL
specific	NULL
antigen	NULL
(	NULL
19	NULL
)	NULL
permitting	NULL
an	NULL
induction	NULL
of	NULL
Bel-3	NULL
,	NULL
a	NULL
coactivator	NULL
(	NULL
14	NULL
)	NULL
which	NULL
generates	NULL
,	NULL
with	NULL
p50	NULL
homodimers	NULL
,	NULL
an	NULL
active	NULL
trimer	NULL
on	NULL
the	NULL
HIV-LTR	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
thymocytes	NULL
p50	NULL
homodimers	NULL
are	NULL
underrepresented	NULL
with	NULL
respect	NULL
to	NULL
p50-p65	NULL
heterodimers	NULL
,	NULL
which	NULL
are	NULL
permanently	NULL
activated	NULL
by	NULL
TNF	NULL
and	NULL
IL-1	NULL
within	NULL
the	NULL
thymic	NULL
microenvironment	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
TNF	NULL
and	NULL
IL-1	NULL
induce	NULL
LTR	NULL
transactivation	NULL
.	NULL

Another	NULL
specificity	NULL
of	NULL
the	NULL
thymocytes	NULL
and	NULL
the	NULL
thymic	NULL
microenvironment	NULL
is	NULL
that	NULL
these	NULL
cytokines	NULL
can	NULL
not	NULL
efficiently	NULL
function	NULL
without	NULL
IL-7	NULL
.	NULL

Together	NULL
with	NULL
our	NULL
previous	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
here	NULL
that	NULL
to	NULL
sustain	NULL
efficient	NULL
HIV	NULL
replication	NULL
,	NULL
thymocytes	NULL
require	NULL
cytokines	NULL
responsible	NULL
for	NULL
their	NULL
activation	NULL
through	NULL
NF-kB	NULL
(	NULL
TNF	NULL
and	NULL
IL-1	NULL
)	NULL
and	NULL
for	NULL
their	NULL
survival	NULL
(	NULL
GM-CSF	NULL
)	NULL
(	NULL
27	NULL
,	NULL
30	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
cytokine	NULL
which	NULL
seems	NULL
to	NULL
fulfill	NULL
both	NULL
functions	NULL
(	NULL
IL-7	NULL
)	NULL
(	NULL
1	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Through	NULL
these	NULL
cytokines	NULL
,	NULL
the	NULL
thymus	NULL
behaves	NULL
as	NULL
a	NULL
virus	NULL
reservoir	NULL
,	NULL
since	NULL
it	NULL
favors	NULL
the	NULL
maintenance	NULL
of	NULL
a	NULL
high	NULL
viral	NULL
load	NULL
in	NULL
certain	NULL
subpopulations	NULL
of	NULL
thymocytes	NULL
(	NULL
8a	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
prolonged	NULL
life	NULL
span	NULL
of	NULL
these	NULL
thymocytes	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Sonia	NULL
Berrih-Aknin	NULL
and	NULL
Claude	NULL
Planché	NULL
(	NULL
hospital	NULL
Marie	NULL
Lannelongue	NULL
,	NULL
Le	NULL
Plessis-Robinson	NULL
,	NULL
France	NULL
)	NULL
for	NULL
providing	NULL
us	NULL
with	NULL
thymuses	NULL
from	NULL
infants	NULL
undergoing	NULL
cardiac	NULL
surgery	NULL
.	NULL

We	NULL
thank	NULL
A.	NULL
Israél	NULL
for	NULL
providing	NULL
us	NULL
with	NULL
antibodies	NULL
against	NULL
NF-kB	NULL
subunits	NULL
and	NULL
for	NULL
a	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
thank	NULL
N.	NULL
Rice	NULL
for	NULL
providing	NULL
us	NULL
with	NULL
IxBa-DN	NULL
expression	NULL
vector	NULL
,	NULL
and	NULL
we	NULL
thank	NULL
S.	NULL
Mémet	NULL
for	NULL
the	NULL
EFla-fBgal	NULL
vector	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Agence	NULL
Nationale	NULL
pour	NULL
la	NULL
Recher-che	NULL
sur	NULL
le	NULL
SIDA	NULL
(	NULL
ANRS	NULL
)	NULL
.	NULL

L.	NULL
Chéne	NULL
is	NULL
a	NULL
fellow	NULL
of	NULL
the	NULL
French	NULL
Ministry	NULL
of	NULL
Education	NULL
and	NULL
Research	NULL
(	NULL
MENESR	NULL
)	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Akashi	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Kondo	NULL
,	NULL
U.	NULL
von	NULL
Freeden	NULL
,	NULL
U.	NULL
Jeffry	NULL
,	NULL
R.	NULL
Murray	NULL
,	NULL
and	NULL
I	NULL
L.	NULL
Weissman	NULL
.	NULL

1997	NULL
.	NULL

Bcl-2	NULL
rescues	NULL
T	NULL
lymphopoiesis	NULL
in	NULL
interleukin-7	NULL
receptor-deficient	NULL
mice	NULL
.	NULL

Cell	NULL
89:1033-1041	NULL
.	NULL

2	NULL
.	NULL

Autran	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
Guiet	NULL
,	NULL
M.	NULL
Raphael	NULL
,	NULL
M.	NULL
Grandadam	NULL
,	NULL
H.	NULL
Agut	NULL
,	NULL
D.	NULL
Candotti	NULL
,	NULL
P.	NULL
Grenot	NULL
,	NULL
F.	NULL
Puech	NULL
,	NULL
P.	NULL
Debré	NULL
,	NULL
and	NULL
J.-Y	NULL
.	NULL

Cesbron	NULL
.	NULL

1996	NULL
.	NULL

Thymocytes	NULL
and	NULL
thymic	NULL
microenvironment	NULL
alterations	NULL
during	NULL
a	NULL
systemic	NULL
HIV	NULL
infection	NULL
in	NULL
a	NULL
severe	NULL
combined	NULL
immunodeficient	NULL
mouse	NULL
model	NULL
.	NULL

AIDS	NULL
10:717-727	NULL
.	NULL

3	NULL
.	NULL

Bach	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Brashler	NULL
.	NULL

1995	NULL
.	NULL

Evidence	NULL
that	NULL
granulocyte/macro-phage-colony-stimulating	NULL
factor	NULL
and	NULL
interferon-gamma	NULL
maintain	NULL
the	NULL
viability	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
in	NULL
part	NULL
by	NULL
their	NULL
suppression	NULL
of	NULL
IL-10	NULL
production	NULL
.	NULL

Int	NULL
.	NULL

Arch	NULL
.	NULL

Allergy	NULL
Immunol	NULL
.	NULL

107:90-92	NULL
.	NULL

4	NULL
.	NULL

Bachelerie	NULL
,	NULL
F.	NULL
,	NULL
M.	NULL
S.	NULL
Rodriguez	NULL
,	NULL
C.	NULL
Dargemont	NULL
,	NULL
D.	NULL
Rousset	NULL
,	NULL
D.	NULL
Thomas	NULL
,	NULL
J.	NULL
L.	NULL
Virelizier	NULL
,	NULL
and	NULL
F.	NULL
Arenzana-Seisdedos	NULL
.	NULL

1997	NULL
.	NULL

Nuclear	NULL
export	NULL
signal	NULL
of	NULL
IxBa	NULL
interferes	NULL
with	NULL
the	NULL
Rev-dependent	NULL
posttranscriptional	NULL
regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
I.	NULL
J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

110:2883-2893	NULL
.	NULL

5	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
1996	NULL
.	NULL

The	NULL
NF-kappa	NULL
B	NULL
and	NULL
I	NULL
kappa	NULL
B	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:649-683	NULL
.	NULL

6	NULL
.	NULL

Braun	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Valentin	NULL
,	NULL
M.	NULL
'T	NULL
.	NULL

Nugeyre	NULL
,	NULL
H.	NULL
Ohayon	NULL
,	NULL
P.	NULL
Gounon	NULL
,	NULL
and	NULL
S.	NULL
F.	NULL
Barré-Sinoussi	NULL
.	NULL

1996	NULL
.	NULL

Productive	NULL
and	NULL
persistent	NULL
infection	NULL
of	NULL
human	NULL
thymic	NULL
epithelial	NULL
cells	NULL
in	NULL
vitro	NULL
with	NULL
HIV-1	NULL
.	NULL

Virology	NULL
225:413-418	NULL
.	NULL

7	NULL
.	NULL

Burkly	NULL
,	NULL
L.	NULL
,	NULL
C.	NULL
Hession	NULL
,	NULL
L.	NULL
Ogata	NULL
,	NULL
C.	NULL
Reilly	NULL
,	NULL
L.	NULL
A.	NULL
Marconi	NULL
,	NULL
D.	NULL
Olson	NULL
,	NULL
R.	NULL
Tizard	NULL
,	NULL
R.	NULL
Cate	NULL
,	NULL
and	NULL
D.	NULL
Lo	NULL
.	NULL

1995	NULL
.	NULL

Expression	NULL
of	NULL
relB	NULL
is	NULL
required	NULL
for	NULL
the	NULL
development	NULL
of	NULL
thymic	NULL
medulla	NULL
and	NULL
dendritic	NULL
cells	NULL
.	NULL

Nature	NULL
373:531-536	NULL
.	NULL

8	NULL
.	NULL

Chen	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
enhance	NULL
virus	NULL
replication	NULL
yet	NULL
are	NULL
not	NULL
absolutely	NULL
required	NULL
for	NULL
viral	NULL
growth	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:5495-5504	NULL
.	NULL

8a.Chéne	NULL
,	NULL
L.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

9	NULL
.	NULL

Coffin	NULL
,	NULL
J.	NULL
M.	NULL
1995	NULL
.	NULL

HIV	NULL
population	NULL
dynamics	NULL
in	NULL
vivo	NULL
:	NULL
implications	NULL
for	NULL
genetic	NULL
variation	NULL
,	NULL
pathogenesis	NULL
,	NULL
and	NULL
therapy	NULL
.	NULL

Science	NULL
267:483-489	NULL
.	NULL

10	NULL
.	NULL

Dub	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
W.	NULL
J.	NULL
Maury	NULL
,	NULL
T.	NULL
M.	NULL
Folks	NULL
,	NULL
A.	NULL
S.	NULL
Fauci	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
activates	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
through	NULL
induction	NULL
of	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
the	NULL
long	NULL
J.	NULL
Virou	NULL
.	NULL

terminal	NULL
repeat	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:5974-5978	NULL
.	NULL

11	NULL
.	NULL

Feuillard	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Dargemont	NULL
,	NULL
V.	NULL
Ferreira	NULL
,	NULL
N.	NULL
Tarantino	NULL
,	NULL
P.	NULL
Debre	NULL
,	NULL
M.	NULL
Raphael	NULL
,	NULL
and	NULL
M.	NULL
Korner	NULL
.	NULL

1997	NULL
.	NULL

Nuclear	NULL
Rel-A	NULL
and	NULL
c-Rel	NULL
protein	NULL
complexes	NULL
are	NULL
differentially	NULL
distributed	NULL
within	NULL
human	NULL
thymocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:2585-2591	NULL
.	NULL

12	NULL
.	NULL

Fisher	NULL
,	NULL
M.	NULL
,	NULL
I.	NULL
MacNeil	NULL
,	NULL
T.	NULL
Suda	NULL
,	NULL
J.	NULL
Cupp	NULL
,	NULL
K.	NULL
Shortman	NULL
,	NULL
and	NULL
A.	NULL
Zlotnik	NULL
.	NULL

1991	NULL
.	NULL

Cytokines	NULL
production	NULL
by	NULL
mature	NULL
and	NULL
immature	NULL
thymocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:3452-3456	NULL
.	NULL

13	NULL
.	NULL

Flory	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
Hoffmeyer	NULL
,	NULL
U.	NULL
Smola	NULL
,	NULL
U.	NULL
R.	NULL
Rapp	NULL
,	NULL
and	NULL
J.	NULL
T.	NULL
Bruder	NULL
.	NULL

1996	NULL
.	NULL

Raf-1	NULL
kinase	NULL
targets	NULL
GA-binding	NULL
protein	NULL
in	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
promoter	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:2260-2268	NULL
.	NULL

14	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
H.	NULL
C.	NULL
Liou	NULL
,	NULL
M.	NULL
L.	NULL
Scott	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
candidate	NULL
proto	NULL
oncogene	NULL
Bel-3	NULL
encodes	NULL
a	NULL
transcriptional	NULL
coactivator	NULL
that	NULL
activates	NULL
through	NULL
NF-kappa	NULL
B	NULL
p50	NULL
homodimers	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:1354-1363	NULL
.	NULL

15	NULL
.	NULL

Gaynor	NULL
,	NULL
R.	NULL
B	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
by	NULL
the	NULL
transactivator	NULL
protein	NULL
Tat	NULL
.	NULL

Curr	NULL
.	NULL

Top	NULL
.	NULL

Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

193:51-77	NULL
.	NULL

16	NULL
.	NULL

Giroir	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
T.	NULL
Brown	NULL
,	NULL
and	NULL
B.	NULL
Beutler	NULL
.	NULL

1992	NULL
.	NULL

Constitutive	NULL
synthesis	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:4864-4868	NULL
.	NULL

17	NULL
.	NULL

Gringhuis	NULL
,	NULL
S.	NULL
L	NULL
,	NULL
L.	NULL
Deleij	NULL
,	NULL
E.	NULL
W.	NULL
Verschuren	NULL
,	NULL
P.	NULL
Borger	NULL
,	NULL
and	NULL
E.	NULL
Vellenga	NULL
.	NULL

1997	NULL
.	NULL

Interleukin-7	NULL
upregulates	NULL
the	NULL
interleukin-2-gene	NULL
expression	NULL
in	NULL
activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
by	NULL
enhancing	NULL
the	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
both	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
and	NULL
acti-vator	NULL
protein-1	NULL
.	NULL

Blood	NULL
90:2690-2700	NULL
.	NULL

18	NULL
.	NULL

Harrich	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Garcia	NULL
,	NULL
R.	NULL
Mitsuyasu	NULL
,	NULL
and	NULL
R.	NULL
Gaynor	NULL
.	NULL

1990	NULL
.	NULL

TAR	NULL
independent	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
phorbol	NULL
ester	NULL
stimulated	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:4417-4423	NULL
.	NULL

19	NULL
.	NULL

Hazan	NULL
,	NULL
U.	NULL
,	NULL
D.	NULL
Thomas	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
F.	NULL
Bachelerie	NULL
,	NULL
N.	NULL
Israél	NULL
,	NULL
H.	NULL
Yssel	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
and	NULL
F.	NULL
Arenzana-Seisdedos	NULL
.	NULL

1990	NULL
.	NULL

Stimulation	NULL
of	NULL
a	NULL
human	NULL
T-cell	NULL
clone	NULL
with	NULL
anti-CD3	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
but	NULL
not	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
enhancer-dependent	NULL
transcription	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:7861-7865	NULL
.	NULL

20	NULL
.	NULL

Hellerstein	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
McCune	NULL
.	NULL

1997	NULL
.	NULL

T	NULL
cell	NULL
turnover	NULL
in	NULL
HIV-1	NULL
discase	NULL
.	NULL

Immunity	NULL
7:583-589	NULL
.	NULL

21	NULL
.	NULL

Herbelin	NULL
,	NULL
A.	NULL
,	NULL
F.	NULL
Machavoine	NULL
,	NULL
E.	NULL
Schneider	NULL
,	NULL
M.	NULL
Papiernik	NULL
,	NULL
and	NULL
M.	NULL
Dy	NULL
.	NULL

1992	NULL
.	NULL

IL-7	NULL
is	NULL
requisite	NULL
for	NULL
IL-1-induced	NULL
thymocyte	NULL
proliferation	NULL
.	NULL

Involvement	NULL
of	NULL
IL-7	NULL
in	NULL
the	NULL
synergistic	NULL
effects	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
with	NULL
IL-1	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:99-105	NULL
.	NULL

22	NULL
.	NULL

Herbelin	NULL
,	NULL
A.	NULL
,	NULL
F.	NULL
Machavoine	NULL
,	NULL
A.	NULL
Vicari	NULL
,	NULL
E.	NULL
Schneider	NULL
,	NULL
M.	NULL
Papiemnik	NULL
,	NULL
H.	NULL
Ziltener	NULL
,	NULL
C.	NULL
Penit	NULL
,	NULL
and	NULL
M.	NULL
Dy	NULL
.	NULL

1994	NULL
.	NULL

Endogenous	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
is	NULL
involved	NULL
in	NULL
IL-1-	NULL
and	NULL
IL-7-induced	NULL
murine	NULL
thymocyte	NULL
proliferation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:1973-1981	NULL
.	NULL

23	NULL
.	NULL

Hernandez-Caselles	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
Martinez-Esparza	NULL
,	NULL
D.	NULL
Sancho	NULL
,	NULL
G.	NULL
Rubio	NULL
,	NULL
and	NULL
P.	NULL
Aparicio	NULL
.	NULL

1995	NULL
.	NULL

Interleukin-7	NULL
rescues	NULL
human	NULL
activated	NULL
T	NULL
lymphocytes	NULL
from	NULL
apoptosis	NULL
induced	NULL
by	NULL
glucocorticosteroids	NULL
and	NULL
regulates	NULL
bel-2	NULL
and	NULL
CD25	NULL
expression	NULL
.	NULL

Hum	NULL
.	NULL

Immunol	NULL
.	NULL

43:181-189	NULL
.	NULL

24	NULL
.	NULL

Ho	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
A.	NULL
U.	NULL
Neumann	NULL
,	NULL
A.	NULL
S.	NULL
Perelson	NULL
,	NULL
W.	NULL
Chen	NULL
,	NULL
J.	NULL
M.	NULL
Leonard	NULL
,	NULL
and	NULL
M.	NULL
Markowitz	NULL
.	NULL

1995	NULL
.	NULL

Rapid	NULL
turnover	NULL
of	NULL
plasma	NULL
virions	NULL
and	NULL
CD4	NULL
lymphocytes	NULL
in	NULL
HIV-1	NULL
infection	NULL
.	NULL

Nature	NULL
373:123-126	NULL
.	NULL

25	NULL
.	NULL

Israél	NULL
,	NULL
A.	NULL
,	NULL
O.	NULL
Yano	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
M.	NULL
Kieran	NULL
,	NULL
and	NULL
P.	NULL
Kourilsky	NULL
.	NULL

1989	NULL
.	NULL

Two	NULL
purified	NULL
factors	NULL
bind	NULL
to	NULL
the	NULL
same	NULL
sequence	NULL
in	NULL
the	NULL
enhancer	NULL
of	NULL
mouse	NULL
MHC	NULL
class	NULL
I	NULL
genes	NULL
:	NULL
one	NULL
of	NULL
them	NULL
is	NULL
a	NULL
positive	NULL
regulator	NULL
induced	NULL
upon	NULL
differentiation	NULL
of	NULL
teratocarcinoma	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:5245-5257	NULL
.	NULL

25a.Israél	NULL
,	NULL
A	NULL
.	NULL

Personal	NULL
communication	NULL
.	NULL

26	NULL
.	NULL

Israél	NULL
,	NULL
N.	NULL
,	NULL
U.	NULL
Hazan	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
A.	NULL
Munier	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
Bachelerie	NULL
,	NULL
A.	NULL
Israél	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Virelizier	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
stimulates	NULL
transcription	NULL
of	NULL
HIV-1	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
independently	NULL
and	NULL
syner-gistically	NULL
with	NULL
mitogens	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:3956-3960	NULL
.	NULL

27	NULL
.	NULL

Iversen	NULL
,	NULL
P.	NULL
O.	NULL
,	NULL
L.	NULL
B	NULL
.	NULL

To	NULL
,	NULL
and	NULL
A.	NULL
F.	NULL
Lopez	NULL
.	NULL

1996	NULL
.	NULL

Apoptosis	NULL
of	NULL
hemopoictic	NULL
cells	NULL
by	NULL
the	NULL
human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
mutant	NULL
E21R	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:2785-2789	NULL
.	NULL

28	NULL
.	NULL

Joshi	NULL
,	NULL
V.	NULL
V.	NULL
,	NULL
J.	NULL
M.	NULL
Oleske	NULL
,	NULL
S.	NULL
Saad	NULL
,	NULL
C.	NULL
Gadol	NULL
,	NULL
E.	NULL
Connor	NULL
,	NULL
R.	NULL
Bobila	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Minnefor	NULL
.	NULL

1986	NULL
.	NULL

Thymus	NULL
biopsy	NULL
in	NULL
children	NULL
with	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
.	NULL

Arch	NULL
.	NULL

Pathol	NULL
.	NULL

Lab	NULL
.	NULL

Med	NULL
.	NULL

110:837-842	NULL
.	NULL

29	NULL
.	NULL

Kinoshita	NULL
,	NULL
S.	NULL
,	NULL
L.	NULL
S.	NULL
Su	NULL
,	NULL
M.	NULL
Amano	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
H.	NULL
Kaneshima	NULL
,	NULL
and	NULL
G.	NULL
P.	NULL
Nolan	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
T	NULL
cell	NULL
activation	NULL
factor	NULL
NF-ATc	NULL
positively	NULL
regulates	NULL
HIV-1	NULL
replication	NULL
and	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Immunity	NULL
6:235-244	NULL
.	NULL

30	NULL
.	NULL

Kinoshita	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Yokoda	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
A.	NULL
Miyajima	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
Bcl-2	NULL
expression	NULL
by	NULL
oncogenic	NULL
Ras	NULL
protein	NULL
in	NULL
hematopoctic	NULL
cells	NULL
.	NULL

Oncogene	NULL
10:2207-2212	NULL
.	NULL

31	NULL
.	NULL

Kitano	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
N.	NULL
Abboud	NULL
,	NULL
D.	NULL
H.	NULL
Ryan	NULL
,	NULL
S.	NULL
G.	NULL
Quan	NULL
,	NULL
G.	NULL
C.	NULL
Baldwin	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Golde	NULL
.	NULL

1991	NULL
.	NULL

Macrophage-active	NULL
colony-stimulating	NULL
factors	NULL
enhance	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
in	NULL
bone	NULL
marrow	NULL
stem	NULL
cells	NULL
.	NULL

Blood	NULL
77:1699-1705	NULL
.	NULL

32	NULL
.	NULL

Kitchen	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
C.	NULL
H.	NULL
Uittenbogaart	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Zack	NULL
.	NULL

1997	NULL
.	NULL

Mechanism	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
localization	NULL
in	NULL
CD4-negative	NULL
thymo-cytes-differentiation	NULL
from	NULL
a	NULL
CD4-positive	NULL
precursor	NULL
allows	NULL
productive	NULL
infection	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:5713-5722	NULL
.	NULL

33	NULL
.	NULL

Kopp	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1995	NULL
.	NULL

NF-kappa	NULL
B	NULL
and	NULL
rel	NULL
proteins	NULL
in	NULL
innate	NULL
immunity	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

58:1-27	NULL
.	NULL

34	NULL
.	NULL

Le	NULL
,	NULL
P.	NULL
T.	NULL
,	NULL
S.	NULL
Lazorick	NULL
,	NULL
L.	NULL
P.	NULL
Whichard	NULL
,	NULL
Y.-C.	NULL
Yang	NULL
,	NULL
S.	NULL
C.	NULL
Clark	NULL
,	NULL
B.	NULL
F.	NULL
Haynes	NULL
,	NULL
and	NULL
K.	NULL
H.	NULL
Singer	NULL
.	NULL

1990	NULL
.	NULL

Human	NULL
thymic	NULL
epithelial	NULL
cells	NULL
produce	NULL
IL-6	NULL
,	NULL
gran-	NULL
voL	NULL
.	NULL

73	NULL
,	NULL
1999	NULL
35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50.	NULL
ulocyte-monocyte-CSF	NULL
,	NULL
and	NULL
leukemia	NULL
inhibitory	NULL
factor	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145	NULL
:	NULL
3310-3315	NULL
.	NULL

Leonard	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Parrott	NULL
,	NULL
W.	NULL
A.	NULL
Buckler	NULL
,	NULL
W.	NULL
Turner	NULL
,	NULL
E.	NULL
K.	NULL
Ross	NULL
,	NULL
M.	NULL
A.	NULL
Martin	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
NF-kappa	NULL
B	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
are	NULL
not	NULL
required	NULL
for	NULL
virus	NULL
infectivity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:4919-4924	NULL
.	NULL

Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
E.	NULL
W.	NULL
Shores	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Love	NULL
.	NULL

1995	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
common	NULL
cytokine	NULL
receptor	NULL
gamma	NULL
chain	NULL
in	NULL
cytokine	NULL
signaling	NULL
and	NULL
lymphoid	NULL
development	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

148:97-114	NULL
.	NULL

Lernbecher	NULL
,	NULL
T.	NULL
,	NULL
U.	NULL
Muller	NULL
,	NULL
and	NULL
T.	NULL
Wirth	NULL
.	NULL

1993	NULL
.	NULL

Distinct	NULL
NF-kappa	NULL
B/Rel	NULL
transcription	NULL
factors	NULL
are	NULL
responsible	NULL
for	NULL
tissue-specific	NULL
and	NULL
inducible	NULL
gene	NULL
activation	NULL
.	NULL

Nature	NULL
365:767-770	NULL
.	NULL

Lin	NULL
,	NULL
J.	NULL
X.	NULL
,	NULL
T.	NULL
S.	NULL
Migone	NULL
,	NULL
M.	NULL
Tsang	NULL
,	NULL
M.	NULL
Friedmann	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Weatherbee	NULL
,	NULL
L.	NULL
Zhou	NULL
,	NULL
A.	NULL
Yamauchi	NULL
,	NULL
E.	NULL
T.	NULL
Bloom	NULL
,	NULL
J.	NULL
Mictz	NULL
,	NULL
S.	NULL
John	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
role	NULL
of	NULL
shared	NULL
receptor	NULL
motifs	NULL
and	NULL
common	NULL
Stat	NULL
proteins	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
cytokine	NULL
pleiotropy	NULL
and	NULL
redundancy	NULL
by	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
IL-13	NULL
,	NULL
and	NULL
IL-15	NULL
.	NULL

Immunity	NULL
2331-339	NULL
.	NULL

May	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1997	NULL
.	NULL

Rel/NF-kappa	NULL
B	NULL
and	NULL
I	NULL
kappa	NULL
B	NULL
proteins	NULL
:	NULL
an	NULL
overview	NULL
.	NULL

Semin	NULL
.	NULL

Cancer	NULL
Biol	NULL
.	NULL

8:63-73	NULL
.	NULL

McCune	NULL
,	NULL
J.	NULL
M.	NULL
1997	NULL
.	NULL

Thymic	NULL
function	NULL
in	NULL
HIV-1	NULL
disease	NULL
.	NULL

Semin	NULL
.	NULL

Immunol	NULL
.	NULL

9:397-404	NULL
.	NULL

Montgomery	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Dallman	NULL
.	NULL

1997	NULL
.	NULL

Semi-quantitative	NULL
polymerase	NULL
chain	NULL
reaction	NULL
analysis	NULL
of	NULL
cytokine	NULL
and	NULL
cytokine	NULL
receptor	NULL
gene	NULL
expression	NULL
during	NULL
thymic	NULL
ontogeny	NULL
.	NULL

Cytokine	NULL
9:717-726	NULL
.	NULL

Murray	NULL
,	NULL
R.	NULL
,	NULL
T.	NULL
Suda	NULL
,	NULL
N.	NULL
Wrighton	NULL
,	NULL
F.	NULL
Lee	NULL
,	NULL
and	NULL
A.	NULL
Zlotnik	NULL
.	NULL

1989	NULL
.	NULL

IL-7	NULL
is	NULL
a	NULL
growth	NULL
and	NULL
maintenance	NULL
factor	NULL
for	NULL
mature	NULL
and	NULL
immature	NULL
thymocyte	NULL
subsets	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

1:526-531	NULL
.	NULL

Okazaki	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Ito	NULL
,	NULL
T.	NULL
Sudo	NULL
,	NULL
M.	NULL
Hattori	NULL
,	NULL
S.	NULL
Kano	NULL
,	NULL
Y.	NULL
Katsura	NULL
,	NULL
and	NULL
N.	NULL
Minato	NULL
.	NULL

1989	NULL
.	NULL

IL-7	NULL
promoters	NULL
thymocyte	NULL
proliferation	NULL
and	NULL
maintains	NULL
immu-nocompetent	NULL
thymocytes	NULL
bearing	NULL
alpha	NULL
beta	NULL
or	NULL
gamma	NULL
delta	NULL
T-cell	NULL
receptors	NULL
in	NULL
vitro	NULL
:	NULL
synergism	NULL
with	NULL
IL-2	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:2917-2922	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
kappa	NULL
B.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
:	NULL
2336-2340	NULL
.	NULL

Papiernik	NULL
,	NULL
M.	NULL
,	NULL
Y.	NULL
Brossard	NULL
,	NULL
N.	NULL
Mulliez	NULL
,	NULL
J.	NULL
Roume	NULL
,	NULL
C.	NULL
Brechot	NULL
,	NULL
F.	NULL
Barin	NULL
,	NULL
A.	NULL
Goudeau	NULL
,	NULL
J.	NULL
F.	NULL
Bach	NULL
,	NULL
C.	NULL
Griscelli	NULL
,	NULL
R.	NULL
Henrion	NULL
,	NULL
and	NULL
R.	NULL
Vazeux	NULL
.	NULL

1992	NULL
.	NULL

Thymic	NULL
abnormalities	NULL
in	NULL
fetuses	NULL
aborted	NULL
from	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
seropositive	NULL
women	NULL
.	NULL

Pediatrics	NULL
89:297-301	NULL
.	NULL

Plum	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
M.	NULL
De	NULL
,	NULL
G.	NULL
Leclercq	NULL
,	NULL
B.	NULL
Verhasselt	NULL
,	NULL
and	NULL
B.	NULL
Vandekerckhove	NULL
.	NULL

1996	NULL
.	NULL

Interleukin-7	NULL
is	NULL
a	NULL
critical	NULL
growth	NULL
factor	NULL
in	NULL
carly	NULL
human	NULL
T-cell	NULL
development	NULL
.	NULL

Blood	NULL
88:4239-4245	NULL
.	NULL

Rosenzweig	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
P.	NULL
Clark	NULL
,	NULL
and	NULL
G.	NULL
N.	NULL
Gaulton	NULL
.	NULL

1993	NULL
.	NULL

Selective	NULL
thymocyte	NULL
depletion	NULL
in	NULL
neonatal	NULL
HIV-1	NULL
thymic	NULL
infection	NULL
.	NULL

AIDS	NULL
7:1601-1605	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Chéne	NULL
,	NULL
M.	NULL
Nugeyre	NULL
,	NULL
F.	NULL
Barré-Sinoussi	NULL
,	NULL
and	NULL
N.	NULL
Israél	NULL
.	NULL

1998	NULL
.	NULL

Contact	NULL
with	NULL
thymic	NULL
epithelial	NULL
cells	NULL
as	NULL
a	NULL
prerequisite	NULL
for	NULL
cytokines	NULL
enhanced	NULL
HIV-1	NULL
replication	NULL
in	NULL
thymocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

72:5852-5861	NULL
.	NULL

Sakata	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Iwagami	NULL
,	NULL
Y.	NULL
Tsuruta	NULL
,	NULL
H.	NULL
Teraoka	NULL
,	NULL
Y.	NULL
Tatsumi	NULL
,	NULL
Y.	NULL
Kita	NULL
,	NULL
S.	NULL
Nishikawa	NULL
,	NULL
Y.	NULL
Takai	NULL
,	NULL
and	NULL
H.	NULL
Fujiwara	NULL
.	NULL

1990	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
IL-7	NULL
mRNA	NULL
and	NULL
production	NULL
of	NULL
IL-7	NULL
by	NULL
a	NULL
cloned	NULL
thymic	NULL
stromal	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Leu-koc	NULL
.	NULL

Biol	NULL
.	NULL

48:205-209	NULL
.	NULL

Sanchez-Pescador	NULL
,	NULL
R.	NULL
,	NULL
M.	NULL
Power	NULL
,	NULL
P.	NULL
Barr	NULL
,	NULL
K.	NULL
Steimer	NULL
,	NULL
M.	NULL
Stempien	NULL
,	NULL
S.	NULL
Brown-Shimer	NULL
,	NULL
W.	NULL
Gee	NULL
,	NULL
A.	NULL
Renard	NULL
,	NULL
A.	NULL
Randolph	NULL
,	NULL
and	NULL
J	NULL
.	NULL

Levy	NULL
.	NULL

1985	NULL
.	NULL

Nucle-otide	NULL
sequence	NULL
and	NULL
expression	NULL
of	NULL
an	NULL
AIDS-associated	NULL
retrovirus	NULL
(	NULL
ARV-2	NULL
)	NULL
.	NULL

Science	NULL
227:484-494	NULL
.	NULL

NF-	NULL
«	NULL
B-DEPENDENT	NULL
HIV-1	NULL
REPLICATION	NULL
IN	NULL
THYMUS	NULL
51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

2073	NULL
Santee	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Owen	NULL
.	NULL

1996	NULL
.	NULL

Human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
p75/80	NULL
(	NULL
CD120b	NULL
)	NULL
gene	NULL
structure	NULL
and	NULL
promoter	NULL
characterization	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:21151-21159	NULL
.	NULL

Schwartz	NULL
,	NULL
O.	NULL
,	NULL
J.	NULL
Virelizier	NULL
,	NULL
L.	NULL
Montagnier	NULL
,	NULL
and	NULL
U.	NULL
Hazan	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
micro-transfection	NULL
method	NULL
using	NULL
the	NULL
luciferase	NULL
encoding	NULL
reporter	NULL
gene	NULL
for	NULL
the	NULL
assay	NULL
of	NULL
HIV	NULL
LTR	NULL
promoter	NULL
activity	NULL
.	NULL

Gene	NULL
88:197-205	NULL
.	NULL

Seth	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
R.	NULL
Hodge	NULL
,	NULL
D.	NULL
M.	NULL
Thompson	NULL
,	NULL
L.	NULL
Robi	NULL
A.	NULL
P	NULL
:	NULL
iotakis	NULL
,	NULL
D.	NULL
K.	NULL
Watson	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1993	NULL
.	NULL

ETS	NULL
family	NULL
proteins	NULL
activate	NULL
transcription	NULL
from	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
9:1017-1023	NULL
.	NULL

Stanley	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
J.	NULL
M.	NULL
McCune	NULL
,	NULL
H.	NULL
Kaneshima	NULL
,	NULL
J.	NULL
S.	NULL
Justement	NULL
,	NULL
M.	NULL
Sullivan	NULL
,	NULL
E.	NULL
Boone	NULL
,	NULL
M.	NULL
Baseler	NULL
,	NULL
J.	NULL
Adelsberger	NULL
,	NULL
M.	NULL
Bonyhadi	NULL
,	NULL
J.	NULL
Orenstein	NULL
,	NULL
C.	NULL
H.	NULL
Fox	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1993	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
infection	NULL
of	NULL
the	NULL
human	NULL
thymus	NULL
and	NULL
disruption	NULL
of	NULL
the	NULL
thymic	NULL
microenvironment	NULL
in	NULL
the	NULL
SCID-hu	NULL
mouse	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1151-1163	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
P.	NULL
Angel	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1993	NULL
.	NULL

Cross-coupling	NULL
of	NULL
the	NULL
NF-kappa-B	NULL
p65	NULL
and	NULL
Fos/Jun	NULL
transcription	NULL
factors	NULL
produces	NULL
potentiated	NULL
biological	NULL
function	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12	NULL
:	NULL
3879-3891	NULL
.	NULL

Su	NULL
,	NULL
L.	NULL
,	NULL
H.	NULL
Kaneshima	NULL
,	NULL
M.	NULL
Bonyhadi	NULL
,	NULL
S.	NULL
Salimi	NULL
,	NULL
D.	NULL
Kraft	NULL
,	NULL
L.	NULL
Rabin	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
McCune	NULL
.	NULL

1995	NULL
.	NULL

HIV-1-induced	NULL
thymocyte	NULL
depletion	NULL
is	NULL
associated	NULL
with	NULL
indirect	NULL
cytopathicity	NULL
and	NULL
infection	NULL
of	NULL
progenitor	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

Immunity	NULL
2:25-36	NULL
.	NULL

Sudo	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Nishikawa	NULL
,	NULL
N.	NULL
Ohno	NULL
,	NULL
N.	NULL
Akiyama	NULL
,	NULL
M.	NULL
Tamakoshi	NULL
,	NULL
H.	NULL
Yoshida	NULL
,	NULL
and	NULL
S.	NULL
Nishikawa	NULL
.	NULL

1993	NULL
.	NULL

Expression	NULL
and	NULL
function	NULL
of	NULL
the	NULL
interleukin	NULL
7	NULL
receptor	NULL
in	NULL
murine	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:9125-9129	NULL
.	NULL

Tanaka	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
W.	NULL
C.	NULL
Hatch	NULL
,	NULL
Y.	NULL
Kress	NULL
,	NULL
R.	NULL
Soeiro	NULL
,	NULL
T.	NULL
Calvelli	NULL
,	NULL
W.	NULL
K.	NULL
Rash-baum	NULL
,	NULL
A.	NULL
Rubinstein	NULL
,	NULL
and	NULL
W.	NULL
D.	NULL
Lyman	NULL
.	NULL

1992	NULL
.	NULL

HIV-1	NULL
infection	NULL
of	NULL
human	NULL
fetal	NULL
thymocytes	NULL
.	NULL

J	NULL
.	NULL

Acquired	NULL
Immune	NULL
Defic	NULL
.	NULL

Syndr	NULL
.	NULL

5:94-101	NULL
.	NULL

Uittenbogaart	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
D.	NULL
J.	NULL
Anisman	NULL
,	NULL
B.	NULL
D.	NULL
Jamieson	NULL
,	NULL
S.	NULL
Kitchen	NULL
,	NULL
I.	NULL
Schmid	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Zack	NULL
,	NULL
and	NULL
E.	NULL
F.	NULL
Hays	NULL
.	NULL

1996	NULL
.	NULL

Differential	NULL
tropism	NULL
of	NULL
HIV-1	NULL
isolates	NULL
for	NULL
distinct	NULL
thymocyte	NULL
subsets	NULL
in	NULL
vitro	NULL
.	NULL

AIDS	NULL
10:9-16	NULL
.	NULL

Valentin	NULL
,	NULL
H.	NULL
,	NULL
M.-T.	NULL
Nugeyre	NULL
,	NULL
F.	NULL
Vuillier	NULL
,	NULL
L.	NULL
Boumsell	NULL
,	NULL
M.	NULL
Schmid	NULL
,	NULL
F.	NULL
Barré-Sinoussi	NULL
,	NULL
and	NULL
R.	NULL
Pereira	NULL
.	NULL

1994	NULL
.	NULL

Two	NULL
subpopulations	NULL
of	NULL
human	NULL
triple-negative	NULL
thymic	NULL
cells	NULL
are	NULL
susceptible	NULL
to	NULL
infection	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:3041-3050	NULL
.	NULL

Wei	NULL
,	NULL
X.	NULL
,	NULL
S.	NULL
K.	NULL
Ghosh	NULL
,	NULL
M.	NULL
E.	NULL
Taylor	NULL
,	NULL
V.	NULL
A.	NULL
Johnson	NULL
,	NULL
E.	NULL
A.	NULL
Emini	NULL
,	NULL
P.	NULL
Deutsch	NULL
,	NULL
J.	NULL
D.	NULL
Lifson	NULL
,	NULL
S.	NULL
Bonhoefer	NULL
,	NULL
M.	NULL
A.	NULL
Nowak	NULL
,	NULL
B.	NULL
H.	NULL
Hahn	NULL
,	NULL
M.	NULL
S.	NULL
Saag	NULL
,	NULL
and	NULL
G.	NULL
M.	NULL
Shaw	NULL
.	NULL

1995	NULL
.	NULL

Viral	NULL
dynamics	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
.	NULL

Nature	NULL
373:117-122	NULL
.	NULL

Weib	NULL
,	NULL
F.	NULL
,	NULL
D.	NULL
Carrasco	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1994	NULL
.	NULL

Constitutive	NULL
and	NULL
inducible	NULL
Rel/	NULL
NF-kappa	NULL
B	NULL
activities	NULL
in	NULL
mouse	NULL
thymus	NULL
and	NULL
spleen	NULL
.	NULL

Oncogene	NULL
9:3289-3297	NULL
.	NULL

Whiteside	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Ernst	NULL
,	NULL
O.	NULL
Lebail	NULL
,	NULL
C.	NULL
Laurent-Winter	NULL
,	NULL
N.	NULL
Rice	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1995	NULL
.	NULL

N-	NULL
and	NULL
C-terminal	NULL
sequences	NULL
control	NULL
degradation	NULL
of	NULL
MAD3/I	NULL
«	NULL
Ba	NULL
in	NULL
response	NULL
to	NULL
inducers	NULL
of	NULL
NF-kappa	NULL
B	NULL
activity	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:5339-5345	NULL
.	NULL

Whiteside	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1997	NULL
.	NULL

I	NULL
kappa	NULL
B	NULL
proteins	NULL
:	NULL
structure	NULL
,	NULL
function	NULL
and	NULL
regulation	NULL
.	NULL

Semin	NULL
.	NULL

Cancer	NULL
Biol	NULL
.	NULL

8:75-82	NULL
.	NULL

Withersward	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
R.	NULL
G.	NULL
Amado	NULL
,	NULL
P.	NULL
S.	NULL
Koka	NULL
,	NULL
B.	NULL
D.	NULL
Jamieson	NULL
,	NULL
A.	NULL
H.	NULL
Kaplan	NULL
,	NULL
I.	NULL
Chen	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Zack	NULL
.	NULL

1997	NULL
.	NULL

Transient	NULL
renewal	NULL
of	NULL
thymopoiesis	NULL
in	NULL
HIV-infected	NULL
human	NULL
thymic	NULL
implants	NULL
following	NULL
antiviral	NULL
therapy	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

3:1102-1109	NULL
.	NULL

Wolf	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
and	NULL
A.	NULL
Cohen	NULL
.	NULL

1992	NULL
.	NULL

Expression	NULL
of	NULL
cytokines	NULL
and	NULL
their	NULL
receptors	NULL
by	NULL
human	NULL
thymocytes	NULL
and	NULL
thymic	NULL
stromal	NULL
cells	NULL
.	NULL

Immunology	NULL
77:362-368	NULL
.	NULL

Zuniga-Pfliicker	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
D.	NULL
Jiang	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1995	NULL
.	NULL

Requirement	NULL
for	NULL
TNF-	NULL
«	NULL
and	NULL
IL-la	NULL
in	NULL
fetal	NULL
thymocyte	NULL
commitment	NULL
and	NULL
differentiation	NULL
.	NULL

Science	NULL
268:1906-1909	NULL
.	NULL

